WO2019182040A1 - タンパク質繊維のクリンプ方法、タンパク質繊維の製造方法、タンパク質繊維、紡績糸、及びテキスタイル製品 - Google Patents
タンパク質繊維のクリンプ方法、タンパク質繊維の製造方法、タンパク質繊維、紡績糸、及びテキスタイル製品 Download PDFInfo
- Publication number
- WO2019182040A1 WO2019182040A1 PCT/JP2019/011807 JP2019011807W WO2019182040A1 WO 2019182040 A1 WO2019182040 A1 WO 2019182040A1 JP 2019011807 W JP2019011807 W JP 2019011807W WO 2019182040 A1 WO2019182040 A1 WO 2019182040A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- protein
- amino acid
- seq
- sequence
- fiber
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 230
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 224
- 239000000835 fiber Substances 0.000 title claims abstract description 139
- 238000000034 method Methods 0.000 title claims abstract description 65
- 238000002788 crimping Methods 0.000 title claims abstract description 49
- 239000004753 textile Substances 0.000 title claims description 41
- -1 spun yarn Substances 0.000 title description 2
- 238000007380 fibre production Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 claims abstract description 31
- 230000004044 response Effects 0.000 claims abstract description 10
- 108010076876 Keratins Proteins 0.000 claims description 95
- 102000011782 Keratins Human genes 0.000 claims description 95
- 239000007864 aqueous solution Substances 0.000 claims description 50
- 239000012460 protein solution Substances 0.000 claims description 22
- 229920002955 Art silk Polymers 0.000 claims description 17
- 238000007654 immersion Methods 0.000 claims description 16
- 238000004519 manufacturing process Methods 0.000 claims description 16
- 239000011159 matrix material Substances 0.000 claims description 5
- GEHJBWKLJVFKPS-UHFFFAOYSA-N bromochloroacetic acid Chemical compound OC(=O)C(Cl)Br GEHJBWKLJVFKPS-UHFFFAOYSA-N 0.000 claims description 4
- 238000005520 cutting process Methods 0.000 claims 2
- 230000000638 stimulation Effects 0.000 abstract description 3
- 108010022355 Fibroins Proteins 0.000 description 256
- 125000003275 alpha amino acid group Chemical group 0.000 description 234
- 235000018102 proteins Nutrition 0.000 description 158
- 125000000539 amino acid group Chemical group 0.000 description 156
- 241000239290 Araneae Species 0.000 description 67
- 210000004899 c-terminal region Anatomy 0.000 description 62
- 239000004744 fabric Substances 0.000 description 53
- 239000000047 product Substances 0.000 description 37
- 230000000875 corresponding effect Effects 0.000 description 35
- 229940024606 amino acid Drugs 0.000 description 31
- 235000001014 amino acid Nutrition 0.000 description 31
- 150000001413 amino acids Chemical group 0.000 description 30
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 29
- 125000000404 glutamine group Chemical group N[C@@H](CCC(N)=O)C(=O)* 0.000 description 24
- 238000004043 dyeing Methods 0.000 description 23
- 150000007523 nucleic acids Chemical class 0.000 description 23
- 108020004707 nucleic acids Proteins 0.000 description 21
- 102000039446 nucleic acids Human genes 0.000 description 21
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 19
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 19
- 210000004027 cell Anatomy 0.000 description 18
- 239000000243 solution Substances 0.000 description 17
- 238000012217 deletion Methods 0.000 description 14
- 230000037430 deletion Effects 0.000 description 14
- 238000002108 rapid electrokinetic patterning Methods 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 230000002209 hydrophobic effect Effects 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 239000013604 expression vector Substances 0.000 description 12
- 238000003780 insertion Methods 0.000 description 12
- 230000037431 insertion Effects 0.000 description 12
- 244000005700 microbiome Species 0.000 description 12
- 238000006467 substitution reaction Methods 0.000 description 11
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 10
- 238000012986 modification Methods 0.000 description 10
- 230000004048 modification Effects 0.000 description 10
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 9
- 210000003746 feather Anatomy 0.000 description 9
- 239000001963 growth medium Substances 0.000 description 9
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 8
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 8
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 8
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 8
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 238000011109 contamination Methods 0.000 description 8
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 8
- 229960000310 isoleucine Drugs 0.000 description 8
- 230000028327 secretion Effects 0.000 description 8
- 239000004474 valine Substances 0.000 description 8
- 210000002268 wool Anatomy 0.000 description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 7
- 229920001872 Spider silk Polymers 0.000 description 7
- 238000004364 calculation method Methods 0.000 description 7
- 210000004907 gland Anatomy 0.000 description 7
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 7
- 210000005070 sphincter Anatomy 0.000 description 7
- 210000004243 sweat Anatomy 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 6
- 238000012258 culturing Methods 0.000 description 6
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 238000009987 spinning Methods 0.000 description 6
- 239000013598 vector Substances 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 5
- 239000004471 Glycine Substances 0.000 description 5
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 5
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 5
- 208000012886 Vertigo Diseases 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 229930182817 methionine Natural products 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- 235000002639 sodium chloride Nutrition 0.000 description 5
- 230000002194 synthesizing effect Effects 0.000 description 5
- 230000014616 translation Effects 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000255789 Bombyx mori Species 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 102000011632 Caseins Human genes 0.000 description 4
- 108010076119 Caseins Proteins 0.000 description 4
- 241000386111 Cyclosa Species 0.000 description 4
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- 241000238631 Hexapoda Species 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 4
- 241000238902 Nephila clavipes Species 0.000 description 4
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 4
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 235000004279 alanine Nutrition 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 235000018417 cysteine Nutrition 0.000 description 4
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000000502 dialysis Methods 0.000 description 4
- 238000005108 dry cleaning Methods 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 101150082901 ADF3 gene Proteins 0.000 description 3
- 241000272517 Anseriformes Species 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 241000186146 Brevibacterium Species 0.000 description 3
- 241000206602 Eukaryota Species 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 241001467578 Microbacterium Species 0.000 description 3
- 241000238903 Nephila Species 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 3
- 241000607720 Serratia Species 0.000 description 3
- 101710172711 Structural protein Proteins 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 238000013019 agitation Methods 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 229960000723 ampicillin Drugs 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 239000012228 culture supernatant Substances 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000000411 inducer Substances 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 239000004745 nonwoven fabric Substances 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 238000003752 polymerase chain reaction Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 238000011218 seed culture Methods 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 239000002759 woven fabric Substances 0.000 description 3
- 241000298979 Acusilas Species 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 235000017060 Arachis glabrata Nutrition 0.000 description 2
- 244000105624 Arachis hypogaea Species 0.000 description 2
- 235000010777 Arachis hypogaea Nutrition 0.000 description 2
- 235000018262 Arachis monticola Nutrition 0.000 description 2
- 241001157788 Araneus Species 0.000 description 2
- 241000193935 Araneus diadematus Species 0.000 description 2
- 241000356504 Argiope Species 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000555281 Brevibacillus Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000186216 Corynebacterium Species 0.000 description 2
- 241000553108 Dyschiriognatha Species 0.000 description 2
- 241000588722 Escherichia Species 0.000 description 2
- 102000005720 Glutathione transferase Human genes 0.000 description 2
- 108010070675 Glutathione transferase Proteins 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 241000533689 Ordgarius Species 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- 241000589516 Pseudomonas Species 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- 235000019764 Soybean Meal Nutrition 0.000 description 2
- 108010073771 Soybean Proteins Proteins 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 108091081024 Start codon Proteins 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- 239000001045 blue dye Substances 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000000578 dry spinning Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 238000009940 knitting Methods 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 238000013365 molecular weight analysis method Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 235000020232 peanut Nutrition 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 239000013587 production medium Substances 0.000 description 2
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 2
- 239000000985 reactive dye Substances 0.000 description 2
- 229920006297 regenerated protein fiber Polymers 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 229940001941 soy protein Drugs 0.000 description 2
- 239000004455 soybean meal Substances 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000002166 wet spinning Methods 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 108010091324 3C proteases Proteins 0.000 description 1
- 101150003973 ADF4 gene Proteins 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- 241000255974 Antheraea Species 0.000 description 1
- 241000304728 Antheraea assamensis Species 0.000 description 1
- 241001235531 Arachnura Species 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000255791 Bombyx Species 0.000 description 1
- 241000498637 Brevibacillus agri Species 0.000 description 1
- 239000012619 Butyl Sepharose® Substances 0.000 description 1
- 125000001433 C-terminal amino-acid group Chemical group 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 241001576020 Chorizopes Species 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000186145 Corynebacterium ammoniagenes Species 0.000 description 1
- 241000533862 Cyrtarachne Species 0.000 description 1
- 229920002271 DEAE-Sepharose Polymers 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000328437 Euprosthenops australis Species 0.000 description 1
- 101710145505 Fiber protein Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000023946 Gasteracantha Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 101710154606 Hemagglutinin Proteins 0.000 description 1
- 241000380914 Hesperus Species 0.000 description 1
- 241000430519 Human rhinovirus sp. Species 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241001575969 Menosira Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- 241001221062 Nephila clavata Species 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 101710093908 Outer capsid protein VP4 Proteins 0.000 description 1
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 1
- 241000488583 Panonychus ulmi Species 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 241000235648 Pichia Species 0.000 description 1
- 241000047292 Poltys Species 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 101710176177 Protein A56 Proteins 0.000 description 1
- 241000589776 Pseudomonas putida Species 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 241000256008 Samia Species 0.000 description 1
- 241001522839 Saturnia japonica Species 0.000 description 1
- 241000235346 Schizosaccharomyces Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 241001123483 Tetragnathidae Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 241000223259 Trichoderma Species 0.000 description 1
- 241000256856 Vespidae Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 238000005571 anion exchange chromatography Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- 210000004507 artificial chromosome Anatomy 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N benzopyrrole Natural products C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 210000000085 cashmere Anatomy 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000011098 chromatofocusing Methods 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 239000013601 cosmid vector Substances 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 239000003398 denaturant Substances 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 239000000982 direct dye Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000012527 feed solution Substances 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 238000001641 gel filtration chromatography Methods 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 108091014693 glutathione binding proteins Proteins 0.000 description 1
- 229960004198 guanidine Drugs 0.000 description 1
- 229960000789 guanidine hydrochloride Drugs 0.000 description 1
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 1
- 238000009998 heat setting Methods 0.000 description 1
- 239000000185 hemagglutinin Substances 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000002169 hydrotherapy Methods 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 238000001155 isoelectric focusing Methods 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 238000007379 mule spinning Methods 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- AJDUTMFFZHIJEM-UHFFFAOYSA-N n-(9,10-dioxoanthracen-1-yl)-4-[4-[[4-[4-[(9,10-dioxoanthracen-1-yl)carbamoyl]phenyl]phenyl]diazenyl]phenyl]benzamide Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C=CC=C2NC(=O)C(C=C1)=CC=C1C(C=C1)=CC=C1N=NC(C=C1)=CC=C1C(C=C1)=CC=C1C(=O)NC1=CC=CC2=C1C(=O)C1=CC=CC=C1C2=O AJDUTMFFZHIJEM-UHFFFAOYSA-N 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000001668 nucleic acid synthesis Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 238000000164 protein isolation Methods 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000001044 red dye Substances 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 108010064995 silkworm fibroin Proteins 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000005030 transcription termination Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
- 239000001043 yellow dye Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
- C07K14/43518—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from spiders
-
- D—TEXTILES; PAPER
- D02—YARNS; MECHANICAL FINISHING OF YARNS OR ROPES; WARPING OR BEAMING
- D02G—CRIMPING OR CURLING FIBRES, FILAMENTS, THREADS, OR YARNS; YARNS OR THREADS
- D02G1/00—Producing crimped or curled fibres, filaments, yarns, or threads, giving them latent characteristics
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M15/00—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment
- D06M15/01—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment with natural macromolecular compounds or derivatives thereof
- D06M15/15—Proteins or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F4/00—Monocomponent artificial filaments or the like of proteins; Manufacture thereof
- D01F4/02—Monocomponent artificial filaments or the like of proteins; Manufacture thereof from fibroin
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M2101/00—Chemical constitution of the fibres, threads, yarns, fabrics or fibrous goods made from such materials, to be treated
- D06M2101/02—Natural fibres, other than mineral fibres
- D06M2101/10—Animal fibres
- D06M2101/12—Keratin fibres or silk
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06P—DYEING OR PRINTING TEXTILES; DYEING LEATHER, FURS OR SOLID MACROMOLECULAR SUBSTANCES IN ANY FORM
- D06P1/00—General processes of dyeing or printing textiles, or general processes of dyeing leather, furs, or solid macromolecular substances in any form, classified according to the dyes, pigments, or auxiliary substances employed
- D06P1/44—General processes of dyeing or printing textiles, or general processes of dyeing leather, furs, or solid macromolecular substances in any form, classified according to the dyes, pigments, or auxiliary substances employed using insoluble pigments or auxiliary substances, e.g. binders
- D06P1/46—General processes of dyeing or printing textiles, or general processes of dyeing leather, furs, or solid macromolecular substances in any form, classified according to the dyes, pigments, or auxiliary substances employed using insoluble pigments or auxiliary substances, e.g. binders using compositions containing natural macromolecular substances or derivatives thereof
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06P—DYEING OR PRINTING TEXTILES; DYEING LEATHER, FURS OR SOLID MACROMOLECULAR SUBSTANCES IN ANY FORM
- D06P5/00—Other features in dyeing or printing textiles, or dyeing leather, furs, or solid macromolecular substances in any form
- D06P5/002—Locally enhancing dye affinity of a textile material by chemical means
Definitions
- This invention relates to protein fiber crimping.
- Patent Document 1 JP2014-129639 discloses an artificial protein fiber similar to silk thread.
- Patent Document 2 (WO2017-038814) discloses that fibers such as wool and cashmere are immersed in an aqueous solution of hydrolyzed keratin derived from feathers and the like. *
- artificial protein fiber does not have a scale on its surface.
- Artificial protein fibers are basically flat, have no bends, and are not crimped. Furthermore, unlike polyamide fibers, it cannot be crimped by applying stress under heating. The same applies to regenerated protein fibers such as casein protein fibers and semi-synthetic protein fibers such as sinone.
- Textile products using uncrimped fibers have a problem with the texture, and in particular, the touch that makes them feel swollen is insufficient.
- Textile products made of fibers without crimps and scales cannot be shrunk.
- shrinking is a process in which a textile product immersed in water collides against a container wall or the like of a container to apply force to the textile product and entangle the fibers with each other. Textile products shrink due to shrinkage.
- This invention Providing a novel method for crimping protein fibers or spun yarns thereof, and a method for producing crimped protein fibers; Providing a method for crimping a textile product comprising the protein fiber or spun yarn; and It is an issue to provide.
- a protein fiber having a crimping property that crimps in response to a stimulus is immersed in a protein solution having a composition different from that of the protein fiber, and the protein having a different composition is penetrated into the protein fiber.
- a protein solution having a composition different from that of the protein fiber is immersed in a protein solution having a composition different from that of the protein fiber, and the protein having a different composition is penetrated into the protein fiber.
- a protein fiber having a crimping property that crimps in response to a stimulus is immersed in a protein solution having a composition different from that of the protein fiber, and the composition is contained inside the protein fiber. Crimp by infiltrating different proteins.
- a protein fiber having a crimping property that is crimped in response to a stimulus is used as a base fiber (protein base fiber), and proteins having different compositions permeate and crimp inside the base fiber.
- the present invention also resides in a spun yarn in which a plurality of the above-described protein fiber staples are twisted together.
- the present invention also resides in a textile product using the above protein fiber or the above spun yarn.
- the protein fiber (protein matrix fiber) is made of an artificial protein.
- the artificial protein is an artificial silk protein.
- staples cut from protein fiber filaments are immersed in the protein solution.
- a spun yarn obtained by twisting a plurality of staples is dipped in the protein solution.
- the textile product made of the spun yarn is immersed in the protein solution to shrink the textile product.
- the textile product is immersed in the protein solution under a condition in which no impact is applied to the textile product.
- the protein solution is an aqueous solution of hydrolyzed keratin.
- the number average molecular weight of hydrolyzed keratin is 500 or more and 5000 or less.
- the keratin concentration of the aqueous solution of hydrolyzed keratin before immersion of the textile product is 0.1 mass% to 2 mass%, and the immersion time is 5 minutes to 120 minutes.
- the temperature of the aqueous solution of hydrolyzed keratin is 30 ° C or higher and 60 ° C or lower.
- protein fibers are crimped by infiltrating proteins having different compositions into the protein matrix fibers.
- the spun yarn is swollen and the texture is improved.
- the term “crimping in response to a stimulus” means that there is a property of crimping due to a stimulus such as contact with moisture.
- Stimulation is not limited to water, but may be contact with other solvents or crosslinking agents, heating, radiation irradiation, or the like.
- an aqueous solvent may be used instead of water.
- the staple When a crimp is formed by a method such as indentation or heat setting, the staple may be stretched in the spinning process and the crimp may weaken, but the crimp is restored by infiltrating proteins with different compositions into the protein base fiber. Can be made.
- the protein fiber may be an artificial protein obtained by modifying a part of the amino acid sequence of a naturally derived protein (for example, 10% or less of the amino acid sequence).
- the artificial protein is particularly preferably an artificial silk protein.
- the protein fiber may be a fiber containing a semi-synthetic protein such as promix, sinon, or a regenerated protein such as casein protein, peanut protein, corn protein, and soy protein.
- the protein fiber may consist of only one type of protein or may consist of a plurality of types of proteins.
- the protein fiber may be a blend of artificial protein fiber and wool or silk.
- protein fibers those other than animal hair such as wool lack the surface scale and are not crimped originally.
- a protein fiber staple is immersed in a protein solution having a different composition and the protein having a different composition is infiltrated into the protein fiber, the crimp becomes remarkable and the feeling of swelling of the spun yarn increases.
- Textile products are fabrics such as knitted fabrics, woven fabrics and non-woven fabrics, or apparel products such as clothing, handkerchiefs, towels, footwear, curtains and table cloths, and industrial products such as car seats.
- the textile product is immersed in the protein solution under conditions that do not apply impact to the textile product, for example, conditions that do not apply impact due to collision of the protein solution with the container wall of the container.
- it can be contracted not by external force applied to the textile product but by contact between the protein solution and the textile product. Therefore, even delicate textile products can be shrunk without causing damage.
- the protein solution is an aqueous solution of hydrolyzed keratin.
- hydrolyzed keratin When hydrolyzed keratin is used, the texture of the treated textile product is superior to hydrolyzed silk or the like. Particularly preferred is hydrolyzed keratin derived from feathers. It is also important to use low molecular weight hydrolyzed keratin, and the number average molecular weight is preferably 500 or more and 5000 or less, particularly 500 or more and 3000 or less. Because of the low molecular weight, keratin penetrates into the staples.
- the keratin concentration of the aqueous solution of hydrolyzed keratin before immersion of the textile product is preferably 0.1 mass% to 2 mass%, and the immersion time is preferably 5 minutes to 120 minutes. In this range, the inventor has confirmed that the texture of the spun yarn can be improved by crimping the staple, and that the textile product can be crimped.
- the temperature of the aqueous solution of hydrolyzed keratin is preferably 30 ° C or higher and 60 ° C or lower. If it is less than 30 ° C, the onset of crimp is slow, and if it exceeds 60 ° C, the textile product soaked becomes hard and the texture is lowered.
- the spun yarn of the present invention a plurality of staples cut from protein fibers having a crimp property that crimps in response to a stimulus are twisted together, proteins having a composition different from that of the protein fibers penetrate into the staples, and the staples are Crimping.
- the texture of the spun yarn is improved by the expression of the crimp.
- the protein fiber is not particularly limited as long as it has a crimping property that crimps in response to stimulation, and may be, for example, a structural protein fiber or an artificial protein fiber.
- a protein having a composition different from that of protein fiber is hydrolyzed keratin.
- the present invention also resides in a textile product comprising the above-described spun yarn. If the protein is infiltrated at the stage of the spun yarn, crimping occurs, and the spun yarn is crimped at that time. In addition, if the protein is infiltrated after making it into a textile product, crimping occurs and shrinkage occurs.
- the protein fiber is made of an artificial protein, and the protein fiber dyeability is improved by a protein having a different composition such as hydrolyzed keratin.
- the protein fiber of the present invention is made of an artificial protein, and the dyeability of the protein fiber is improved by a protein having a different composition such as hydrolyzed keratin.
- the protein having a different composition is hydrolyzed keratin, and the protein fiber is immersed in an aqueous solution of hydrolyzed keratin for 40 minutes or more and 80 minutes or less.
- a fiber made of an artificial protein is immersed in hydrolyzed keratin, a peak of keratin absorption occurs when the immersion time is around 60 minutes. Therefore, a large amount of keratin can penetrate into the artificial protein fiber in an immersion time of around 40 minutes to 80 minutes.
- the protein constituting the protein fiber may be a structural protein, and the structural protein may be fibroin.
- Fibroin may be natural fibroin or modified fibroin (artificial fibroin).
- the modified fibroin may be silk fibroin, and this modified silk fibroin may be one in which a hydrophobic amino acid residue is artificially introduced, or a hydrophilic amino acid residue is artificial. It may be introduced in the above.
- the modified fibroin is a protein containing a domain sequence represented by Formula 1: [(A) n motif-REP] m or Formula 2: [(A) n motif-REP] m- (A) n motif.
- an amino acid sequence (N-terminal sequence and C-terminal sequence) may be further added to either one or both of the N-terminal side and the C-terminal side of the domain sequence.
- the N-terminal sequence and the C-terminal sequence are not limited to these, but are typically regions having no amino acid motif repeat characteristic of fibroin and consisting of about 100 amino acids.
- modified fibroin means an artificially produced fibroin (artificial fibroin).
- the modified fibroin may be a fibroin whose domain sequence is different from the amino acid sequence of naturally occurring fibroin or may be the same as the amino acid sequence of naturally occurring fibroin.
- Natural fibroin as used herein is also represented by Formula 1: [(A) n motif-REP] m or Formula 2: [(A) n motif-REP] m- (A) n motif.
- a protein comprising a domain sequence to be processed.
- the amino acid sequence of naturally-occurring fibroin may be used as it is, and it depends on the amino acid sequence of naturally-occurring fibroin.
- the amino acid sequence may be modified (for example, the amino acid sequence may be modified by modifying the gene sequence of a naturally-derived fibroin that has been cloned), or it may be artificially designed without relying on the naturally-occurring fibroin. And those synthesized (for example, those having a desired amino acid sequence by chemically synthesizing a nucleic acid encoding the designed amino acid sequence).
- domain sequence means a crystalline region (typically corresponding to the (A) n motif of the amino acid sequence) and an amorphous region (typically the amino acid sequence of the silk fibroin).
- a crystalline region typically corresponding to the (A) n motif of the amino acid sequence
- an amorphous region typically the amino acid sequence of the silk fibroin.
- Formula 1 [(A) n motif-REP] m
- Formula 2 [(A) n motif-REP] m- (A) n motif.
- (A) n motif represents an amino acid sequence mainly composed of alanine residues, and n is 2 to 27. n may be an integer from 2 to 20, 4 to 27, 4 to 20, 8 to 20, 10 to 20, 4 to 16, 8 to 16, or 10 to 16.
- the ratio of the number of alanine residues to the total number of amino acid residues in the (A) n motif may be 40% or more, such as 60% or more, 70% or more, 80% or more, 83% or more, 85% or more, It may be 86% or more, 90% or more, 95% or more, or 100% (meaning that it is composed only of alanine residues).
- a plurality of (A) n motifs present in the domain sequence may be composed of at least seven alanine residues alone.
- REP indicates an amino acid sequence composed of 2 to 200 amino acid residues.
- REP may be an amino acid sequence composed of 10 to 200 amino acid residues.
- m represents an integer of 2 to 300, and may be an integer of 10 to 300.
- a plurality of (A) n motifs may have the same amino acid sequence or different amino acid sequences.
- Plural REPs may have the same amino acid sequence or different amino acid sequences.
- the modified fibroin is, for example, a modification of the amino acid sequence corresponding to, for example, substitution, deletion, insertion and / or addition of one or more amino acid residues to the cloned natural fibroin gene sequence. Can be obtained at Substitution, deletion, insertion and / or addition of amino acid residues can be carried out by methods well known to those skilled in the art such as partial-directed mutagenesis. Specifically, Nucleic Acid Res. 10, 6487 (1982), Methods in Enzymology, 100, 448 (1983), and the like.
- Naturally-derived fibroin is a protein containing a domain sequence represented by Formula 1: [(A) n motif-REP] m or Formula 2: [(A) n motif-REP] m- (A) n motif.
- Specific examples include fibroin produced by insects or spiders.
- fibroin produced by insects include, for example, Bombyx mori, Kwako (Bombyx mandaraina), Tengea (Antheraea yamanai), ⁇ ⁇ (Antereaperanii), ⁇ ⁇ (Eriothyraminey) ), Silkworms produced by silkworms, such as Samia cythia, chestnut worms (Caligula japonica), Chuser moth (Antherea mylitta), Antheraea assama, and vespax (Vespaxia spp.) Hornet silk protein.
- fibroin produced by insects include silkworm fibroin L chain (GenBank accession number M76430 (base sequence) and AAA27840.1 (amino acid sequence)).
- Fibroin produced by spiders includes, for example, spiders belonging to the genus spider (Araneus spp.) Such as the spider spider, the spider spider, the red spider spider, and the bean spider, the genus spiders of the genus Araneus, the spider spider spider, the spider spider genus e Spiders, spiders such as spiders, spiders belonging to the genus Spider, spiders belonging to the genus Pronos, spiders belonging to the genus Trinofunda, such as Torinofundamas (genus Cyrtarachne) Spiders belonging to the genus (Gasteracantha), spiders belonging to the genus Spider (Ordgarius genus), such as the spiders, the spiders, and the spiders belonging to the genus Ordgarius Spiders belonging to the genus Argiope, such as the genus Argiope, spiders belonging to the genus Arachnura, such as the white-tailed spider, spiders belonging to the
- Spiders belonging to the genus Azumigumi (Menosira), spiders belonging to the genus Dyschiriognatha (genus Dyschiriognatha) such as the common spider spider, the black spider spider, the genus Spider genus belonging to the genus Spider belonging to the genus (L) and the genus Spider belonging to the genus (L) Produced by spiders belonging to the family Tetragnathidae such as spiders belonging to the genus Prostenops
- Examples include spider silk protein.
- the spider silk protein include dragline proteins such as MaSp (MaSp1 and MaSp2) and ADF (ADF3 and ADF4), MiSp (MiSp1 and MiSp2), and the like.
- spider silk proteins produced by spiders include, for example, fibroin-3 (adf-3) [derived from Araneus diadematus] (GenBank accession numbers AAC47010 (amino acid sequence), U47855 (base sequence)), fibroin-4 (adf-4) [derived from Araneus diadematus] (GenBank accession number AAC47011 (amino acid sequence), U47856 (base sequence)), dragline silk protein spiroin 1 [derived from Nephila clavipes] (GenBank accession number 4) ), U37520 (base sequence)), major ampulate spidro n 1 [derived from Latroductus hesperus] (GenBank accession number ABR68856 (amino acid sequence), EF595246 (base sequence)), dragline silk protein spidolin 2 [derived from Nephila clavata (GenBank accession number AAL32 base sequence 44 AAL32 base sequence amino acid 44, amino acid sequence 44 AAL47)
- Naturally derived fibroin include fibroin whose sequence information is registered in NCBI GenBank.
- sequence information is registered in NCBI GenBank.
- spidin, sample, fibroin, “silk and polypeptide”, or “silk and protein” is described as a keyword in DEFINITION from sequences including INV as DIVISION among the sequence information registered in NCBI GenBank. It can be confirmed by extracting a character string of a specific product from the sequence, CDS, and a sequence in which the specific character string is described from SOURCE to TISSUE TYPE.
- the modified fibroin may be modified silk fibroin (modified silk protein amino acid sequence produced by silkworm), modified spider silk fibroin (modified spider silk protein amino acid sequence produced by spiders) Thing). Among them, modified spider silk fibroin is preferably used.
- modified fibroin examples include a modified fibroin derived from a large sphincter bookmark silk protein produced in a spider large bottle gland, a modified fibroin with a reduced content of glycine residues, (A) an n motif Modified fibroin with reduced content, content of glycine residue, and (A) modified fibroin with reduced content of n motif.
- Examples of the modified fibroin derived from the large sphincter bookmark silk protein produced in the spider large bottle gland include a protein containing a domain sequence represented by Formula 1: [(A) n motif-REP] m .
- n is preferably an integer of 3 to 20, more preferably an integer of 4 to 20, and more preferably 8 to 20.
- An integer is further preferred, an integer of 10 to 20 is still more preferred, an integer of 4 to 16 is still more preferred, an integer of 8 to 16 is particularly preferred, and an integer of 10 to 16 is most preferred.
- the number of amino acid residues constituting REP is preferably 10 to 200 residues. More preferably, it is ⁇ 150 residues, more preferably 20-100 residues, and even more preferably 20-75 residues.
- a modified fibroin derived from the large sphincter bookmark silk protein produced in the spider large bottle gland is a glycine residue contained in the amino acid sequence represented by Formula 1: [(A) n motif-REP] m ,
- the total number of residues of serine residues and alanine residues is preferably 40% or more, more preferably 60% or more, still more preferably 70% or more based on the total number of amino acid residues. .
- the modified fibroin derived from the large sphincter bookmark silk protein produced in the spider large bottle gland comprises a unit of an amino acid sequence represented by the formula 1: [(A) n motif-REP] m and has a C-terminal. It may be a polypeptide whose sequence is an amino acid sequence shown in any of SEQ ID NOs: 14 to 16 or an amino acid sequence having 90% or more homology with the amino acid sequence shown in any of SEQ ID NOs: 14 to 16.
- the amino acid sequence shown in SEQ ID NO: 14 is the same as the amino acid sequence consisting of 50 amino acids at the C-terminal of the amino acid sequence of ADF3 (GI: 1263287, NCBI), and the amino acid sequence shown in SEQ ID NO: 15 is the sequence
- the amino acid sequence shown in SEQ ID NO: 14 is identical to the amino acid sequence obtained by removing 20 residues from the C-terminus, and the amino acid sequence shown in SEQ ID NO: 16 is 29 residues removed from the C-terminus of the amino acid sequence shown in SEQ ID NO: 14. It is identical to the amino acid sequence.
- modified fibroin derived from a large sphincter bookmark silk protein produced in the spider large bottle-like gland
- amino acid sequence represented by SEQ ID NO: 17, or (1-ii) sequence Mention may be made of modified fibroin comprising an amino acid sequence having a sequence identity of 90% or more with the amino acid sequence indicated by number 17. The sequence identity is preferably 95% or more.
- the amino acid sequence represented by SEQ ID NO: 17 is an amino acid sequence of ADF3 in which an amino acid sequence (SEQ ID NO: 18) consisting of a start codon, His10 tag and an HRV3C protease (Human rhinovirus 3C protease) recognition site is added to the N-terminus.
- the 13th repeat region was increased to approximately double, and the translation was mutated to terminate at the 1154th amino acid residue.
- the C-terminal amino acid sequence of the amino acid sequence shown in SEQ ID NO: 17 is identical to the amino acid sequence shown in SEQ ID NO: 16.
- the modified fibroin (1-i) may be composed of the amino acid sequence represented by SEQ ID NO: 17.
- the modified fibroin with a reduced content of glycine residues has an amino acid sequence with a reduced content of glycine residues in the domain sequence compared to naturally occurring fibroin. It can be said that the modified fibroin has an amino acid sequence corresponding to at least one or more glycine residues in REP substituted with another amino acid residue as compared with naturally occurring fibroin.
- Modified fibroin with a reduced content of glycine residues has a domain sequence of GGX and GPGXX in REP (where G is a glycine residue, P is a proline residue, X Is an amino acid residue other than glycine.)
- G is a glycine residue
- P is a proline residue
- X is an amino acid residue other than glycine.
- this corresponds to substitution of one glycine residue in at least one or more of the motif sequences with another amino acid residue. It may have an amino acid sequence.
- the ratio of the motif sequence in which the above glycine residue is replaced with another amino acid residue may be 10% or more with respect to the total motif sequence.
- the modified fibroin with a reduced content of glycine residues includes a domain sequence represented by Formula 1: [(A) n motif-REP] m , and is located on the most C-terminal side from the domain sequence (A )
- the number of alanine residues relative to the total number of amino acid residues in the n motif may be 83% or more, preferably 86% or more, more preferably 90% or more, and 95% or more. More preferably, it is 100% (meaning that it is composed only of alanine residues).
- the modified fibroin in which the content of glycine residues is reduced is that the content ratio of the amino acid sequence consisting of XGX is increased by substituting one glycine residue of the GGX motif with another amino acid residue. preferable.
- the content ratio of the amino acid sequence consisting of GGX in the domain sequence is preferably 30% or less, more preferably 20% or less, and more preferably 10% or less. More preferably, it is 6% or less, still more preferably 4% or less, still more preferably 2% or less.
- the content ratio of the amino acid sequence consisting of GGX in the domain sequence can be calculated by the same method as the method for calculating the content ratio (z / w) of the amino acid sequence consisting of XGX below.
- a fibroin modified fibroin or naturally-occurring fibroin containing a domain sequence represented by Formula 1: [(A) n motif-REP] m , (A) n located closest to the C-terminal side from the domain sequence
- An amino acid sequence consisting of XGX is extracted from all REPs included in the sequence excluding the sequence from the motif to the C-terminal of the domain sequence.
- z / w (%) can be calculated by dividing z by w.
- z / w is preferably 50.9% or more, more preferably 56.1% or more, and 58.7% or more. Is more preferably 70% or more, still more preferably 80% or more. Although there is no restriction
- a modified fibroin with a reduced content of glycine residues encodes another amino acid residue by substituting at least a part of the base sequence encoding the glycine residue from the cloned gene sequence of naturally occurring fibroin. It can obtain by modifying so that. At this time, one glycine residue in GGX motif and GPGXX motif may be selected as a glycine residue to be modified, or substitution may be performed so that z / w is 50.9% or more.
- an amino acid sequence satisfying the above-described aspect can be designed from the amino acid sequence of naturally derived fibroin, and a nucleic acid encoding the designed amino acid sequence can be obtained by chemical synthesis.
- one or more amino acid residues are further substituted or deleted.
- the amino acid sequence corresponding to the insertion and / or addition may be modified.
- the other amino acid residue is not particularly limited as long as it is an amino acid residue other than glycine residue, but valine (V) residue, leucine (L) residue, isoleucine (I) residue, methionine ( M) hydrophobic amino acid residues such as proline (P) residue, phenylalanine (F) residue and tryptophan (W) residue, glutamine (Q) residue, asparagine (N) residue, serine (S ) Residues, lysine (K) residues and glutamic acid (E) residues are preferred, and valine (V) residues, leucine (L) residues, isoleucine (I) residues and glutamine ( Q) residue is more preferable, and glutamine (Q) residue is more preferable.
- modified fibroin with a reduced content of glycine residues (2-i) the amino acid sequence represented by SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 10 or SEQ ID NO: 12, or (2- ii)
- SEQ ID NO: 3 amino acid sequence represented by SEQ ID NO: 4, SEQ ID NO: 10 or SEQ ID NO: 12, or
- 2- ii A modified fibroin containing an amino acid sequence having 90% or more sequence identity with the amino acid sequence shown in SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 10 or SEQ ID NO: 12 can be mentioned.
- the modified fibroin (2-i) will be described.
- the amino acid sequence represented by SEQ ID NO: 3 is obtained by substituting GQX for all GGX in the REP of the amino acid sequence represented by SEQ ID NO: 1 corresponding to naturally occurring fibroin.
- the amino acid sequence represented by SEQ ID NO: 4 is the amino acid sequence represented by SEQ ID NO: 3, in which every two (A) n motifs are deleted from the N-terminal side to the C-terminal side, and further before the C-terminal sequence.
- One [(A) n motif-REP] is inserted into the.
- the amino acid sequence shown in SEQ ID NO: 10 has two alanine residues inserted in the C-terminal side of each (A) n motif of the amino acid sequence shown in SEQ ID NO: 4, and a part of glutamine (Q) residues. Substituted with a serine (S) residue and a part of the amino acid at the N-terminal side is deleted so as to be almost the same as the molecular weight of SEQ ID NO: 4.
- the amino acid sequence represented by SEQ ID NO: 12 is a region of 20 domain sequences present in the amino acid sequence represented by SEQ ID NO: 9 (however, several amino acid residues on the C-terminal side of the region are substituted). Is a sequence in which a His tag is added to the C-terminal of the sequence repeated four times.
- the value of z / w in the amino acid sequence represented by SEQ ID NO: 1 is 46.8%.
- the z / w values in the amino acid sequence shown in SEQ ID NO: 3, the amino acid sequence shown in SEQ ID NO: 4, the amino acid sequence shown in SEQ ID NO: 10, and the amino acid sequence shown in SEQ ID NO: 12 are 58.7%, 70.1%, 66.1% and 70.0%.
- the x / y values of the amino acid sequences shown in SEQ ID NOs: 1, 3, 4, 10 and 12 at a jagged ratio (described later) of 1: 1.8 to 11.3 are 15.0% and 15. 0%, 93.4%, 92.7% and 89.3%.
- the modified fibroin (2-i) may be composed of the amino acid sequence represented by SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 10 or SEQ ID NO: 12.
- the modified fibroin (2-ii) includes an amino acid sequence having 90% or more sequence identity with the amino acid sequence represented by SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 10 or SEQ ID NO: 12.
- the modified fibroin of (2-ii) is also a protein containing a domain sequence represented by Formula 1: [(A) n motif-REP] m .
- the sequence identity is preferably 95% or more.
- the modified fibroin of (2-ii) has a sequence identity of 90% or more with the amino acid sequence represented by SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 10 or SEQ ID NO: 12, and is contained in REP (XGX ( Where X is an amino acid residue other than glycine.) Z / w where z is the total number of amino acid residues of the amino acid sequence consisting of z and w is the total number of amino acid residues of REP in the domain sequence. Is preferably 50.9% or more.
- modified fibroin may contain a tag sequence at one or both of the N-terminal and C-terminal. This makes it possible to isolate, immobilize, detect and visualize the modified fibroin.
- tag sequences include affinity tags that use specific affinity (binding property, affinity) with other molecules.
- affinity tag include a histidine tag (His tag).
- His tag is a short peptide with about 4 to 10 histidine residues, and has the property of binding specifically to metal ions such as nickel. Therefore, the isolation of modified fibroin by metal chelating chromatography (chelating metal chromatography) Can be used.
- Specific examples of the tag sequence include the amino acid sequence represented by SEQ ID NO: 5 (amino acid sequence including a His tag sequence and a hinge sequence).
- GST glutathione-S-transferase
- MBP maltose-binding protein
- an “epitope tag” using an antigen-antibody reaction can also be used.
- a peptide (epitope) exhibiting antigenicity as a tag sequence, an antibody against the epitope can be bound.
- HA peptide sequence of hemagglutinin of influenza virus
- myc tag peptide sequence of hemagglutinin of influenza virus
- FLAG tag peptide sequence of hemagglutinin of influenza virus
- a tag sequence that can be separated with a specific protease can also be used.
- the modified fibroin from which the tag sequence has been separated can also be recovered.
- modified fibroin containing the tag sequence examples include (2-iii) the amino acid sequence represented by SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 11 or SEQ ID NO: 13, or (2-iv) SEQ ID NO: 8 And a modified fibroin containing an amino acid sequence having 90% or more sequence identity with the amino acid sequence shown in SEQ ID NO: 9, SEQ ID NO: 11 or SEQ ID NO: 13.
- amino acid sequences represented by SEQ ID NOs: 6, 7, 8, 9, 11, and 13 are the amino acids represented by SEQ ID NO: 5 at the N-terminus of the amino acid sequences represented by SEQ ID NOs: 1, 2, 3, 4, 10, and 12, respectively.
- a sequence (including a His tag sequence and a hinge sequence) is added.
- the modified fibroin may be composed of the amino acid sequence represented by SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 11 or SEQ ID NO: 13.
- the modified fibroin (2-iv) includes an amino acid sequence having 90% or more sequence identity with the amino acid sequence represented by SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 11 or SEQ ID NO: 13.
- the modified fibroin of (2-iv) is also a protein containing a domain sequence represented by Formula 1: [(A) n motif-REP] m .
- the sequence identity is preferably 95% or more.
- the modified fibroin (2-iv) has an amino acid sequence represented by SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 11 or SEQ ID NO: 13 with a sequence identity of 90% or more, and is contained in XREP ( Where X is an amino acid residue other than glycine.) Z / w where z is the total number of amino acid residues of the amino acid sequence consisting of z and w is the total number of amino acid residues of REP in the domain sequence. Is preferably 50.9% or more.
- the aforementioned modified fibroin may contain a secretion signal for releasing the protein produced in the recombinant protein production system to the outside of the host.
- the sequence of the secretion signal can be appropriately set according to the type of host.
- (A) modified fibroin content of n motifs has been reduced, the domain sequence is compared to the naturally occurring fibroin, having an amino acid sequence reduced the content of (A) n motif. It can be said that the domain sequence of the modified fibroin has an amino acid sequence corresponding to the deletion of at least one or more (A) n motifs as compared to naturally occurring fibroin.
- the modified fibroin in which the content of n motif is reduced may have an amino acid sequence corresponding to 10% to 40% deletion of (A) n motif from naturally occurring fibroin.
- the modified fibroin with a reduced content of n motif has 1 to 3 (A) n motifs in which the domain sequence is at least from the N-terminal side to the C-terminal side compared to naturally occurring fibroin. Each may have an amino acid sequence corresponding to the deletion of one (A) n motif.
- the domain sequence of the modified fibroin is at least two consecutive from the N-terminal side to the C-terminal side compared to the naturally derived fibroin (A) n motif And an amino acid sequence corresponding to the deletion of one (A) n motif repeated in this order.
- (A) modified fibroin content of n motifs has been reduced, the domain sequence, amino acids corresponding to at least the N-terminal side 2 every other towards the C-terminal side (A) n motifs lacking It may have a sequence.
- a modified fibroin with a reduced content of n- motif contains a domain sequence represented by Formula 1: [(A) n- motif-REP] m , and is adjacent to the C-terminal side from the N-terminal side.
- the number of alanine residues relative to the total number of amino acid residues in the n motif may be 83% or more, preferably 86% or more, more preferably 90% or more, and 95% or more. More preferably, it is 100% (meaning that it is composed only of alanine residues).
- FIG. 1 shows a domain sequence obtained by removing the N-terminal sequence and the C-terminal sequence from the modified fibroin.
- the domain sequence is from the N-terminal side (left side): (A) n motif-first REP (50 amino acid residues)-(A) n motif-second REP (100 amino acid residues)-(A) n Motif-third REP (10 amino acid residues)-(A) n motif-fourth REP (20 amino acid residues)-(A) n motif-fifth REP (30 amino acid residues)-(A) It has a sequence called n motif.
- FIG. 1 includes pattern 1 (comparison between the first REP and the second REP, and comparison between the third REP and the fourth REP), pattern 2 (comparison between the first REP and the second REP, and 4th REP and 5th REP), pattern 3 (2nd REP and 3rd REP comparison, 4th REP and 5th REP comparison), pattern 4 (first REP and Comparison of the second REP).
- pattern 1 compare between the first REP and the second REP, and comparison between the third REP and the fourth REP
- pattern 2 comparison between the first REP and the second REP, and 4th REP and 5th REP
- pattern 3 (2nd REP and 3rd REP comparison, 4th REP and 5th REP comparison
- pattern 4 first REP and Comparison of the second REP
- the number of amino acid residues of each REP in the two adjacent [(A) n motif-REP] units selected is compared.
- each pattern the number of all amino acid residues of two adjacent [(A) n motif-REP] units indicated by solid lines is added (not only REP but also (A) the number of amino acid residues of the n motif. is there.). Then, the total value added is compared, and the total value (maximum value of the total value) of the pattern having the maximum total value is set as x. In the example shown in FIG. 1, the total value of pattern 1 is the maximum.
- x / y (%) can be calculated by dividing x by the total number of amino acid residues y of the domain sequence.
- x / y is preferably 50% or more, more preferably 60% or more, still more preferably 65% or more, It is still more preferably 70% or more, still more preferably 75% or more, and particularly preferably 80% or more.
- x / y is preferably 50% or more, more preferably 60% or more, still more preferably 65% or more, It is still more preferably 70% or more, still more preferably 75% or more, and particularly preferably 80% or more.
- x / y is preferably 89.6% or more, and when the jagged ratio is 1: 1.8 to 3.4, x / y / Y is preferably 77.1% or more, and when the jagged ratio is 1: 1.9 to 8.4, x / y is preferably 75.9% or more, and the jagged ratio is 1 In the case of 1.9 to 4.1, x / y is preferably 64.2% or more.
- x / y is 46.4% or more, preferably 50% or more, more preferably 55% or more, still more preferably 60% or more, and 70% or more. Even more preferable, 80% or more is particularly preferable.
- x / y is 46.4% or more, preferably 50% or more, more preferably 55% or more, still more preferably 60% or more, and 70% or more. Even more preferable, 80% or more is particularly preferable.
- x / y is 46.4% or more, preferably 50% or more, more preferably 55% or more, still more preferably 60% or more, and 70% or more. Even more preferable, 80% or more is particularly preferable.
- (A) modified fibroin content of n motif is reduced, for example, encoding a cloned naturally occurring fibroin gene sequences, as x / y is more than 64.2% of the (A) n motif It can be obtained by deleting one or more of the sequences.
- an amino acid sequence corresponding to the deletion of one or more (A) n motifs is designed so that x / y is 64.2% or more from the amino acid sequence of naturally occurring fibroin. It can also be obtained by chemically synthesizing a nucleic acid encoding the amino acid sequence.
- one or more amino acid residues are further substituted, deleted, inserted and / or added.
- the amino acid sequence corresponding to this may be modified.
- the modified fibroin (3-i) will be described.
- the amino acid sequence represented by SEQ ID NO: 2 has the amino acid sequence represented by SEQ ID NO: 1 corresponding to naturally occurring fibroin deleted from the N-terminal side to the C-terminal side every two (A) n motifs Furthermore, one [(A) n motif-REP] is inserted in front of the C-terminal sequence.
- the amino acid sequence shown in SEQ ID NO: 4 is obtained by substituting all GGX in REP of the amino acid sequence shown in SEQ ID NO: 2 with GQX.
- the amino acid sequence shown in SEQ ID NO: 10 has two alanine residues inserted in the C-terminal side of each (A) n motif of the amino acid sequence shown in SEQ ID NO: 4, and a part of glutamine (Q) residues. Substituted with a serine (S) residue and a part of the amino acid at the N-terminal side is deleted so as to be almost the same as the molecular weight of SEQ ID NO: 4.
- the amino acid sequence represented by SEQ ID NO: 12 is a region of 20 domain sequences present in the amino acid sequence represented by SEQ ID NO: 9 (however, several amino acid residues on the C-terminal side of the region are substituted). Is a sequence in which a His tag is added to the C-terminal of the sequence repeated four times.
- the value of x / y of the amino acid sequence represented by SEQ ID NO: 1 (corresponding to naturally-occurring fibroin) at a jagged ratio of 1: 1.8 to 11.3 is 15.0%.
- the value of x / y in the amino acid sequence represented by SEQ ID NO: 2 and the amino acid sequence represented by SEQ ID NO: 4 is 93.4%.
- the value of x / y in the amino acid sequence represented by SEQ ID NO: 10 is 92.7%.
- the value of x / y in the amino acid sequence represented by SEQ ID NO: 12 is 89.3%.
- the z / w values in the amino acid sequences shown in SEQ ID NOs: 1, 2, 4, 10 and 12 are 46.8%, 56.2%, 70.1%, 66.1% and 70.0%, respectively. is there.
- the modified fibroin (3-i) may be composed of the amino acid sequence represented by SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 10 or SEQ ID NO: 12.
- the modified fibroin (3-ii) includes an amino acid sequence having 90% or more sequence identity with the amino acid sequence represented by SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 10 or SEQ ID NO: 12.
- the modified fibroin of (3-ii) is also a protein containing a domain sequence represented by Formula 1: [(A) n motif-REP] m .
- the sequence identity is preferably 95% or more.
- the modified fibroin of (3-ii) has 90% or more sequence identity with the amino acid sequence represented by SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 10 or SEQ ID NO: 12, and from the N-terminal side to the C-terminal side
- the number of amino acid residues of REP of two adjacent [(A) n motif-REP] units is sequentially compared, and the number of amino acid residues of REP having a small number of amino acid residues is 1, the other
- x / y is 64.2% or more, where x is the maximum total value of the total number of bases and y is the total number of amino acid residues in the domain sequence.
- the above-described modified fibroin may contain the above-described tag sequence at one or both of the N-terminal and C-terminal.
- modified fibroin containing the tag sequence examples include (3-iii) an amino acid sequence represented by SEQ ID NO: 7, SEQ ID NO: 9, SEQ ID NO: 11 or SEQ ID NO: 13, or (2-iv) SEQ ID NO: 7 And a modified fibroin containing an amino acid sequence having 90% or more sequence identity with the amino acid sequence shown in SEQ ID NO: 9, SEQ ID NO: 11 or SEQ ID NO: 13.
- amino acid sequences represented by SEQ ID NOs: 6, 7, 8, 9, 11, and 13 are the amino acids represented by SEQ ID NO: 5 at the N-terminus of the amino acid sequences represented by SEQ ID NOs: 1, 2, 3, 4, 10, and 12, respectively.
- a sequence (including a His tag sequence and a hinge sequence) is added.
- the modified fibroin may be composed of the amino acid sequence represented by SEQ ID NO: 7, SEQ ID NO: 9, SEQ ID NO: 11 or SEQ ID NO: 13.
- the modified fibroin (3-iv) includes an amino acid sequence having 90% or more sequence identity with the amino acid sequence represented by SEQ ID NO: 7, SEQ ID NO: 9, SEQ ID NO: 11 or SEQ ID NO: 13.
- the modified fibroin of (3-iv) is also a protein containing a domain sequence represented by Formula 1: [(A) n motif-REP] m .
- the sequence identity is preferably 95% or more.
- the modified fibroin (3-iv) has 90% or more sequence identity with the amino acid sequence represented by SEQ ID NO: 7, SEQ ID NO: 9, SEQ ID NO: 11 or SEQ ID NO: 13, and from the N-terminal side to the C-terminal side.
- the other X is the maximum total value of the total number of amino acid residues of two adjacent [(A) n motif-REP] units with a ratio of the number of amino acid residues of REP of 1.8 to 11.3.
- x / y is preferably 64.2% or more.
- the aforementioned modified fibroin may contain a secretion signal for releasing the protein produced in the recombinant protein production system to the outside of the host.
- the sequence of the secretion signal can be appropriately set according to the type of host.
- the domain sequence of the modified fibroin is different from that of naturally occurring fibroin in addition to at least one or more glycine residues in REP. It can be said to have an amino acid sequence corresponding to substitution with an amino acid residue.
- it is a modified fibroin having the characteristics of the modified fibroin in which the content of the glycine residue is reduced and (A) the modified fibroin in which the content of the n motif is reduced.
- Specific embodiments and the like are as described in the modified fibroin in which the content of glycine residues is reduced and (A) the modified fibroin in which the content of n motif is reduced.
- modified fibroin with reduced glycine residue content and (A) n- motif content (4-i) the amino acid represented by SEQ ID NO: 4, SEQ ID NO: 10 or SEQ ID NO: 12
- a modified fibroin comprising an amino acid sequence having 90% or more sequence identity with the sequence (4-ii) SEQ ID NO: 4, SEQ ID NO: 10 or SEQ ID NO: 12 can be mentioned.
- Specific embodiments of the modified fibroin comprising the amino acid sequence represented by SEQ ID NO: 4, SEQ ID NO: 10 or SEQ ID NO: 12 are as described above.
- the modified fibroin according to another embodiment has a domain sequence in which one or more amino acid residues in REP are replaced with amino acid residues having a large hydrophobicity index as compared to naturally occurring fibroin, and It may have an amino acid sequence including a region having a large hydrophobic index locally, corresponding to the insertion of one or more amino acid residues having a large hydrophobic index in REP.
- the region where the hydrophobic index is locally large is preferably composed of 2 to 4 amino acid residues.
- the amino acid residue having a large hydrophobicity index is an amino acid selected from isoleucine (I), valine (V), leucine (L), phenylalanine (F), cysteine (C), methionine (M) and alanine (A). More preferably, it is a residue.
- the modified fibroin according to the present embodiment has one or more amino acid residues in REP substituted with amino acid residues having a large hydrophobicity index and / or 1 in REP compared to naturally occurring fibroin.
- one or more amino acid residues are substituted, deleted, inserted and / or compared with naturally occurring fibroin.
- the modified fibroin according to the present embodiment for example, hydrophobicizes one or more hydrophilic amino acid residues (for example, amino acid residues having a negative hydrophobicity index) in REP from the gene sequence of naturally-derived fibroin that has been cloned. It can be obtained by substituting amino acid residues (for example, amino acid residues having a positive hydrophobicity index) and / or inserting one or more hydrophobic amino acid residues in REP.
- hydrophilic amino acid residues for example, amino acid residues having a negative hydrophobicity index
- one or more hydrophilic amino acid residues in REP are substituted with hydrophobic amino acid residues from the amino acid sequence of naturally occurring fibroin, and / or one or more hydrophobic amino acid residues in REP It can also be obtained by designing an amino acid sequence corresponding to insertion of, and chemically synthesizing a nucleic acid encoding the designed amino acid sequence.
- one or more hydrophilic amino acid residues in REP have been replaced with hydrophobic amino acid residues from the amino acid sequence of naturally occurring fibroin and / or one or more hydrophobic amino acids in REP
- the amino acid sequence corresponding to the substitution, deletion, insertion and / or addition of one or more amino acid residues may be further modified.
- the modified fibroin according to another embodiment includes a domain sequence represented by Formula 1: [(A) n motif-REP] m , and (A) located at the most C-terminal side of the domain sequence from the n motif.
- P, and (A) where the total number of amino acid residues contained in the sequence excluding the sequence from the n motif to the C terminus of the domain sequence from the domain sequence is q / Q may have an amino acid sequence of 6.2% or more.
- hydrophobicity index of amino acid residues As for the hydrophobicity index of amino acid residues, a known index (Hydropathy index: Kyte J, & Doolittle R (1982) “A simple method for displaying the hydropathic character of bio.p. 7”. 105-132). Specifically, the hydrophobicity index (hydropathic index, hereinafter also referred to as “HI”) of each amino acid is as shown in Table 1 below.
- a sequence obtained by removing the sequence from the domain sequence represented by Formula 1: [(A) n motif-REP] m to the most C-terminal side from the domain (A) n motif to the C terminus of the domain sequence. (Hereinafter referred to as “array A”).
- array A the average value of the hydrophobicity index of four consecutive amino acid residues is calculated.
- the average value of the hydrophobicity index is obtained by dividing the total HI of each amino acid residue contained in the four consecutive amino acid residues by 4 (number of amino acid residues).
- the average value of the hydrophobicity index is obtained for all four consecutive amino acid residues (each amino acid residue is used for calculating the average value 1 to 4 times). Next, a region where the average value of the hydrophobicity index of four consecutive amino acid residues is 2.6 or more is specified. Even if a certain amino acid residue corresponds to a plurality of “four consecutive amino acid residues whose average value of hydrophobicity index is 2.6 or more”, it should be included as one amino acid residue in the region. become.
- the total number of amino acid residues contained in the region is p.
- the total number of amino acid residues contained in sequence A is q.
- the average value of the hydrophobicity index of four consecutive amino acid residues is 2
- p / q is preferably 6.2% or more, more preferably 7% or more, further preferably 10% or more, and 20% or more. Even more preferably, it is still more preferably 30% or more.
- the upper limit of p / q is not particularly limited, but may be 45% or less, for example.
- the modified fibroin according to this embodiment includes, for example, one or a plurality of hydrophilic amino acid residues (for example, hydrophobicity) in the REP so that the amino acid sequence of the naturally-derived fibroin thus cloned satisfies the above p / q condition.
- hydrophilic amino acid residues for example, hydrophobicity
- Substituting a hydrophobic amino acid residue (for example, an amino acid residue having a positive hydrophobicity index) and / or one or more hydrophobic amino acid residues during REP Can be obtained by locally modifying the amino acid sequence to include a region having a large hydrophobicity index.
- an amino acid sequence satisfying the above p / q conditions can be designed from the amino acid sequence of naturally derived fibroin, and a nucleic acid encoding the designed amino acid sequence can be obtained by chemical synthesis.
- one or more amino acid residues in REP were replaced with amino acid residues having a higher hydrophobicity index and / or one or more amino acid residues in REP.
- modifications corresponding to substitution, deletion, insertion and / or addition of one or more amino acid residues may be performed. .
- the amino acid residue having a large hydrophobicity index is not particularly limited, but isoleucine (I), valine (V), leucine (L), phenylalanine (F), cysteine (C), methionine (M) and alanine (A ) are preferred, and valine (V), leucine (L) and isoleucine (I) are more preferred.
- modified fibroin (5-i) the amino acid sequence represented by SEQ ID NO: 20, SEQ ID NO: 22 or SEQ ID NO: 23, or (5-ii) SEQ ID NO: 20, SEQ ID NO: 22 or SEQ ID NO: 23 And a modified fibroin comprising an amino acid sequence having 90% or more sequence identity with the amino acid sequence represented by
- the modified fibroin (5-i) will be described.
- the amino acid sequence shown in SEQ ID NO: 19 is an amino acid sequence in which the alanine residues in the (A) n motif of (A) naturally derived fibroin are deleted so that the number of consecutive alanine residues is five.
- the amino acid sequence represented by SEQ ID NO: 20 is inserted into the amino acid sequence represented by SEQ ID NO: 19 by two amino acid sequences (VLI) each consisting of 3 amino acid residues every other REP, and represented by SEQ ID NO: 19. A part of amino acids on the C-terminal side are deleted so that the molecular weight of the amino acid sequence is almost the same.
- the amino acid sequence represented by SEQ ID NO: 21 is obtained by inserting two alanine residues at the C-terminal side of each (A) n motif with respect to the amino acid sequence represented by SEQ ID NO: 19, and further adding some glutamine (Q) residues. A group is substituted with a serine (S) residue, and a part of amino acids on the C-terminal side is deleted so as to be approximately the same as the molecular weight of the amino acid sequence represented by SEQ ID NO: 19.
- the amino acid sequence represented by SEQ ID NO: 22 is obtained by inserting one amino acid sequence (VLI) consisting of 3 amino acid residues at every other REP to the amino acid sequence represented by SEQ ID NO: 21.
- the amino acid sequence shown in SEQ ID NO: 23 is obtained by inserting two amino acid sequences (VLI) each consisting of 3 amino acid residues into the amino acid sequence shown in SEQ ID NO: 21 every other REP.
- the modified fibroin (5-i) may be composed of the amino acid sequence represented by SEQ ID NO: 20, SEQ ID NO: 22 or SEQ ID NO: 23.
- the modified fibroin (5-ii) includes an amino acid sequence having 90% or more sequence identity with the amino acid sequence represented by SEQ ID NO: 20, SEQ ID NO: 22 or SEQ ID NO: 23.
- the modified fibroin of (5-ii) is also a protein containing a domain sequence represented by Formula 1: [(A) n motif-REP] m .
- the sequence identity is preferably 95% or more.
- the modified fibroin of (5-ii) has a sequence identity of 90% or more with the amino acid sequence represented by SEQ ID NO: 20, SEQ ID NO: 22 or SEQ ID NO: 23, and is located at the most C-terminal side (A) n
- the amino acids included in the region where the average value of the hydrophobicity index of 4 consecutive amino acid residues is 2.6 or more P is the total number of residues
- P / q is preferably 6.2% or more.
- the above-mentioned modified fibroin may contain a tag sequence at one or both of the N-terminal and C-terminal.
- modified fibroin comprising a tag sequence
- 5-iii the amino acid sequence represented by SEQ ID NO: 24, SEQ ID NO: 25 or SEQ ID NO: 26, or (5-iv) SEQ ID NO: 24, SEQ ID NO: 25 or Mention may be made of modified fibroin comprising an amino acid sequence having 90% or more sequence identity with the amino acid sequence shown in SEQ ID NO: 26.
- amino acid sequences represented by SEQ ID NOs: 24, 25 and 26 are the amino acid sequences represented by SEQ ID NO: 5 (including His tag sequence and hinge sequence) at the N-terminus of the amino acid sequences represented by SEQ ID NOs: 20, 22 and 23, respectively. It is added.
- the modified fibroin may consist of the amino acid sequence represented by SEQ ID NO: 24, SEQ ID NO: 25 or SEQ ID NO: 26.
- the modified fibroin (5-iv) includes an amino acid sequence having 90% or more sequence identity with the amino acid sequence represented by SEQ ID NO: 24, SEQ ID NO: 25 or SEQ ID NO: 26.
- the modified fibroin of (5-iv) is also a protein containing a domain sequence represented by Formula 1: [(A) n motif-REP] m .
- the sequence identity is preferably 95% or more.
- the modified fibroin (5-iv) has 90% or more sequence identity with the amino acid sequence represented by SEQ ID NO: 24, SEQ ID NO: 25 or SEQ ID NO: 26, and is located at the most C-terminal side (A) n
- the amino acids included in the region where the average value of the hydrophobicity index of 4 consecutive amino acid residues is 2.6 or more P is the total number of residues
- P / q is preferably 6.2% or more.
- the aforementioned modified fibroin may contain a secretion signal for releasing the protein produced in the recombinant protein production system to the outside of the host.
- the sequence of the secretion signal can be appropriately set according to the type of host.
- the modified fibroin according to still another embodiment has an amino acid sequence in which the content of glutamine residues is reduced as compared with naturally occurring fibroin.
- the modified fibroin according to this embodiment preferably includes at least one motif selected from a GGX motif and a GPGXX motif in the amino acid sequence of REP.
- the content ratio of the GPGXX motif is usually 1% or more, may be 5% or more, and is preferably 10% or more.
- the upper limit of GPGXX motif content rate 50% or less may be sufficient and 30% or less may be sufficient.
- GPGXX motif content is a value calculated by the following method.
- Formula 1 [(A) n motif-REP] m
- Formula 2 [(A) n motif-REP] m- (A) fibroin (modified fibroin or naturally derived) containing a domain sequence represented by the n motif In fibroin), the number of GPGXX motifs contained in the region in all REPs contained in the sequence excluding the sequence from the domain sequence (A) n motif located at the most C-terminal side to the C-terminus of the domain sequence.
- the number obtained by multiplying the total number by three is s, and is located at the most C-terminal side.
- the sequence from the n motif to the C-terminal of the domain sequence is (A) The content ratio of the GPGXX motif is calculated as s / t, where t is the total number of amino acid residues of all REPs excluding the n motif. It is.
- “A sequence located at the most C-terminal side (A) excluding the sequence from the n motif to the C-terminal of the domain sequence from the domain sequence” (A)
- the sequence from the n motif to the C terminus of the domain sequence ”(sequence corresponding to REP) may include a sequence that is not highly correlated with the sequence characteristic of fibroin, and m is small In this case (that is, when the domain sequence is short), the calculation result of the content ratio of the GPGXX motif is affected, so this influence is excluded.
- the “GPGXX motif” is located at the C-terminus of REP, even if “XX” is, for example, “AA”, it is treated as “GPGXX motif”.
- FIG. 3 is a schematic diagram showing the domain sequence of the modified fibroin.
- the modified fibroin according to this embodiment preferably has a glutamine residue content of 9% or less, more preferably 7% or less, still more preferably 4% or less, and preferably 0%. Particularly preferred.
- the “glutamine residue content” is a value calculated by the following method.
- Formula 1 [(A) n motif-REP] m
- Formula 2 [(A) n motif-REP] m-
- the total number of glutamine residues contained in the region is u
- the sequence from the (A) n motif located at the most C-terminal side to the C-terminus of the domain sequence is excluded from the domain sequence
- (A) n The glutamine residue content is calculated as u / t, where t is the total number of amino acid residues in all REPs excluding the motif.
- the reason why "A sequence located at the most C-terminal side (A) excluding the sequence from the n motif to the C-terminus of the domain sequence from the domain sequence" is the reason described above. It is the same.
- the domain sequence has one or more glutamine residues in REP deleted or substituted with other amino acid residues as compared to naturally occurring fibroin. It may have a corresponding amino acid sequence.
- the “other amino acid residue” may be an amino acid residue other than a glutamine residue, but is preferably an amino acid residue having a larger hydrophobicity index than the glutamine residue. Table 1 shows the hydrophobicity index of amino acid residues.
- amino acid residues having a larger hydrophobicity index than glutamine residues include isoleucine (I), valine (V), leucine (L), phenylalanine (F), cysteine (C), methionine (M ) Amino acid residues selected from alanine (A), glycine (G), threonine (T), serine (S), tryptophan (W), tyrosine (Y), proline (P) and histidine (H). it can.
- an amino acid residue selected from isoleucine (I), valine (V), leucine (L), phenylalanine (F), cysteine (C), methionine (M) and alanine (A) is more preferable. More preferred is an amino acid residue selected from among isoleucine (I), valine (V), leucine (L) and phenylalanine (F).
- the hydrophobicity of REP is preferably ⁇ 0.8 or more, more preferably ⁇ 0.7 or more, still more preferably 0 or more, and It is still more preferable that it is 3 or more, and it is especially preferable that it is 0.4 or more.
- the “hydrophobicity of REP” is a value calculated by the following method.
- Formula 1 [(A) n motif-REP] m
- Formula 2 [(A) n motif-REP] m-
- A) the sequence from the n- motif to the C-terminus of the domain sequence located on the most C-terminal side (sequence corresponding to “region A” in FIG. 1) is included.
- the sum of the hydrophobicity index of each amino acid residue in the region is represented by v, and the sequence from the (A) n motif located at the most C-terminal side to the C-terminus of the domain sequence is excluded from the domain sequence, and ( A) The hydrophobicity of REP is calculated as v / t, where t is the total number of amino acid residues of all REPs excluding the n motif.
- t is the total number of amino acid residues of all REPs excluding the n motif.
- the modified fibroin according to the present embodiment has a domain sequence in which one or more glutamine residues in REP are deleted compared to naturally-occurring fibroin and / or one or more glutamine in REP.
- modifications corresponding to substitution of residues with other amino acid residues there are further alterations in amino acid sequence corresponding to substitution, deletion, insertion and / or addition of one or more amino acid residues. Also good.
- the modified fibroin according to the present embodiment includes, for example, deletion of one or more glutamine residues in REP from the cloned gene sequence of natural fibroin and / or one or more glutamine residues in REP. Can be obtained by substituting with other amino acid residues.
- one or more glutamine residues in REP are deleted from the amino acid sequence of naturally occurring fibroin, and / or one or more glutamine residues in REP are replaced with other amino acid residues.
- it can also be obtained by designing a corresponding amino acid sequence and chemically synthesizing a nucleic acid encoding the designed amino acid sequence.
- modified fibroin As more specific examples of the modified fibroin according to the present invention, (6-i) the amino acid represented by SEQ ID NO: 27, SEQ ID NO: 28, SEQ ID NO: 29, SEQ ID NO: 30, SEQ ID NO: 31, SEQ ID NO: 38 or SEQ ID NO: 39 90% or more of the modified fibroin containing the sequence, or (6-ii) the amino acid sequence represented by SEQ ID NO: 27, SEQ ID NO: 28, SEQ ID NO: 29, SEQ ID NO: 30, SEQ ID NO: 31, SEQ ID NO: 38 or SEQ ID NO: 39 Mention may be made of modified fibroin comprising amino acid sequences having sequence identity.
- the (6-i) modified fibroin will be described.
- Amino acid sequence shown in SEQ ID NO: 4 is a fibroin naturally occurring Nephila clavipes (GenBank accession number: P46804.1, GI: 1174415) based on the nucleotide sequence and amino acid sequence of, (A) n
- the amino acid sequence in which the alanine residue in the motif is continued is modified with an amino acid to improve productivity, such as the number of consecutive alanine residues is five.
- Met-PRT410 since Met-PRT410 has not altered the glutamine residue (Q), the glutamine residue content is comparable to the glutamine residue content of naturally occurring fibroin.
- the amino acid sequence represented by SEQ ID NO: 27 (M_PRT888) is obtained by replacing all QQs in Met-PRT410 (SEQ ID NO: 4) with VL.
- the amino acid sequence represented by SEQ ID NO: 28 (M_PRT965) is obtained by substituting all QQs in Met-PRT410 (SEQ ID NO: 4) with TS and substituting the remaining Q with A.
- the amino acid sequence (M_PRT889) represented by SEQ ID NO: 29 is obtained by replacing all QQs in Met-PRT410 (SEQ ID NO: 4) with VL and replacing the remaining Q with I.
- the amino acid sequence (M_PRT916) represented by SEQ ID NO: 30 is obtained by substituting all QQs in Met-PRT410 (SEQ ID NO: 4) with VI and replacing the remaining Q with L.
- the amino acid sequence represented by SEQ ID NO: 31 is obtained by replacing all QQs in Met-PRT410 (SEQ ID NO: 4) with VF and replacing the remaining Q with I.
- the amino acid sequence (M_PRT525) represented by SEQ ID NO: 37 is obtained by inserting two alanine residues into a region (A 5 ) where alanine residues are continuous with respect to Met-PRT410 (SEQ ID NO: 4).
- the two C-terminal domain sequences were deleted and 13 glutamine residues (Q) were replaced with serine residues (S) or proline residues (P) so that they were almost the same as those in FIG.
- the amino acid sequence represented by SEQ ID NO: 38 (M_PRT699) is obtained by substituting VL for all QQs in M_PRT525 (SEQ ID NO: 37).
- the amino acid sequence represented by SEQ ID NO: 39 is obtained by replacing all QQs in M_PRT525 (SEQ ID NO: 37) with VL and replacing the remaining Q with I.
- amino acid sequences represented by SEQ ID NO: 27, SEQ ID NO: 28, SEQ ID NO: 29, SEQ ID NO: 30, SEQ ID NO: 31, SEQ ID NO: 38, and SEQ ID NO: 39 all have a glutamine residue content of 9% or less (Table 2). ).
- the modified fibroin (6-i) may be composed of the amino acid sequence represented by SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 16 or SEQ ID NO: 17. .
- the modified fibroin of (6-ii) has a sequence identity of 90% or more with the amino acid sequence represented by SEQ ID NO: 27, SEQ ID NO: 28, SEQ ID NO: 29, SEQ ID NO: 30, SEQ ID NO: 31, SEQ ID NO: 38 or SEQ ID NO: 39.
- the amino acid sequence having The modified fibroin of (6-ii) is also represented by the formula 1: [(A) n motif-REP] m or the formula 2: [(A) n motif-REP] m- (A) n motif.
- the sequence identity is preferably 95% or more.
- the modified fibroin (6-ii) preferably has a glutamine residue content of 9% or less.
- the modified fibroin (6-ii) preferably has a GPGXX motif content of 10% or more.
- modified fibroin may contain a tag sequence at one or both of the N-terminal and C-terminal. This makes it possible to isolate, immobilize, detect and visualize the modified fibroin.
- modified fibroin containing a tag sequence (6-iii) amino acids represented by SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 19 or SEQ ID NO: 20 90% or more of the modified fibroin containing the sequence, or (6-iv) the amino acid sequence represented by SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 19 or SEQ ID NO: 20 Mention may be made of modified fibroin comprising amino acid sequences having sequence identity.
- amino acid sequences shown by SEQ ID NO: 32, SEQ ID NO: 33, SEQ ID NO: 34, SEQ ID NO: 35, SEQ ID NO: 36, SEQ ID NO: 40 and SEQ ID NO: 41 are SEQ ID NO: 27, SEQ ID NO: 28, SEQ ID NO: 29, SEQ ID NO: 30, respectively.
- the amino acid sequence represented by SEQ ID NO: 5 (including His tag sequence and hinge sequence) is added to the N-terminus of the amino acid sequence represented by SEQ ID NO: 31, SEQ ID NO: 38 and SEQ ID NO: 39.
- the modified fibroin of (6-iii) may be composed of the amino acid sequence represented by SEQ ID NO: 32, SEQ ID NO: 33, SEQ ID NO: 34, SEQ ID NO: 35, SEQ ID NO: 36, SEQ ID NO: 40 or SEQ ID NO: 41. .
- the modified fibroin (6-iv) has a sequence identity of 90% or more with the amino acid sequence represented by SEQ ID NO: 32, SEQ ID NO: 33, SEQ ID NO: 34, SEQ ID NO: 35, SEQ ID NO: 36, SEQ ID NO: 40 or SEQ ID NO: 41.
- the amino acid sequence having The modified fibroin of (6-iv) is also a domain represented by Formula 1: [(A) n motif-REP] m or Formula 2: [(A) n motif-REP] m- (A) n motif.
- the sequence identity is preferably 95% or more.
- the modified fibroin (6-iv) preferably has a glutamine residue content of 9% or less.
- the modified fibroin (6-iv) preferably has a GPGXX motif content of 10% or more.
- the aforementioned modified fibroin may contain a secretion signal for releasing the protein produced in the recombinant protein production system to the outside of the host.
- the sequence of the secretion signal can be appropriately set according to the type of host.
- modified fibroin protein
- the modified fibroin (protein) is transformed with, for example, an expression vector having a nucleic acid sequence encoding the protein and one or more regulatory sequences operably linked to the nucleic acid sequence. It can be produced by expressing the nucleic acid using a host.
- the method for producing the nucleic acid encoding the modified fibroin is not particularly limited.
- the nucleic acid is produced by a method such as amplification by polymerase chain reaction (PCR), cloning, modification by genetic engineering techniques, or chemical synthesis. can do.
- the method for chemically synthesizing nucleic acids is not particularly limited.
- AKTA oligopilot plus 10/100 (GE Healthcare Japan Co., Ltd.) is used based on the amino acid sequence information of proteins obtained from the NCBI web database.
- a gene can be chemically synthesized by a method of linking oligonucleotides that are synthesized automatically by PCR or the like.
- a nucleic acid encoding the modified fibroin consisting of an amino acid sequence in which an amino acid sequence consisting of a start codon and a His10 tag is added to the N terminus of the above amino acid sequence is synthesized. May be.
- Regulatory sequences are sequences that control the expression of modified fibroin in the host (for example, promoters, enhancers, ribosome binding sequences, transcription termination sequences, etc.), and can be appropriately selected depending on the type of host.
- an inducible promoter that functions in the host cell and can induce expression of the modified fibroin may be used.
- An inducible promoter is a promoter that can control transcription by the presence of an inducer (expression inducer), absence of a repressor molecule, or physical factors such as an increase or decrease in temperature, osmotic pressure or pH value.
- the type of expression vector can be appropriately selected according to the type of host, such as a plasmid vector, virus vector, cosmid vector, fosmid vector, artificial chromosome vector, and the like.
- a vector that can replicate autonomously in a host cell or can be integrated into a host chromosome and contains a promoter at a position where a nucleic acid encoding a modified fibroin can be transcribed is preferably used.
- any of prokaryotes and eukaryotes such as yeast, filamentous fungi, insect cells, animal cells and plant cells can be preferably used.
- prokaryotic hosts include bacteria belonging to the genus Escherichia, Brevibacillus, Serratia, Bacillus, Microbacterium, Brevibacterium, Corynebacterium, Pseudomonas and the like.
- microorganisms belonging to the genus Escherichia include Escherichia coli.
- microorganisms belonging to the genus Brevibacillus include Brevibacillus agri and the like.
- microorganisms belonging to the genus Serratia include Serratia liqufaciens and the like.
- microorganisms belonging to the genus Bacillus include Bacillus subtilis.
- microorganisms belonging to the genus Microbacterium include microbacterium / ammonia film.
- microorganisms belonging to the genus Brevibacterium include Brevibacterium divaricatam.
- microorganisms belonging to the genus Corynebacterium include Corynebacterium ammoniagenes.
- microorganisms belonging to the genus Pseudomonas include Pseudomonas putida.
- vectors for introducing a nucleic acid encoding a modified fibroin include, for example, pBTrp2 (manufactured by Boehringer Mannheim), pGEX (manufactured by Pharmacia), pUC18, pBluescriptII, pSupex, pET22b, pCold, pUB110, pNCO2 (Japanese Patent Laid-Open No. 2002-238696) and the like can be mentioned.
- Examples of eukaryotic hosts include yeast and filamentous fungi (molds, etc.).
- yeast include yeasts belonging to the genus Saccharomyces, Pichia, Schizosaccharomyces and the like.
- Examples of the filamentous fungi include filamentous fungi belonging to the genus Aspergillus, the genus Penicillium, the genus Trichoderma and the like.
- examples of a vector into which a nucleic acid encoding a modified fibroin is introduced include YEp13 (ATCC37115) and YEp24 (ATCC37051).
- a method for introducing the expression vector into the host cell any method can be used as long as it is a method for introducing DNA into the host cell.
- a method using calcium ions [Proc. Natl. Acad. Sci. USA, 69, 2110 (1972)]
- electroporation method electroporation method
- spheroplast method protoplast method
- lithium acetate method competent method, and the like.
- a method for expressing a nucleic acid by a host transformed with an expression vector in addition to direct expression, secretory production, fusion protein expression, etc. can be performed according to the method described in Molecular Cloning 2nd edition, etc. .
- the modified fibroin can be produced, for example, by culturing a host transformed with an expression vector in a culture medium, producing and accumulating the protein in the culture medium, and collecting the protein from the culture medium.
- the method for culturing a host in a culture medium can be performed according to a method usually used for culturing a host.
- the culture medium contains a carbon source, nitrogen source, inorganic salts, etc. that can be assimilated by the host, and can efficiently culture the host. If so, either a natural medium or a synthetic medium may be used.
- Any carbon source may be used as long as it can be assimilated by the above-mentioned transformed microorganism.
- Examples thereof include glucose, fructose, sucrose, and carbohydrates such as molasses, starch and starch hydrolyzate, acetic acid and propionic acid, etc.
- Organic acids and alcohols such as ethanol and propanol can be used.
- the nitrogen source examples include ammonium salts of inorganic acids or organic acids such as ammonia, ammonium chloride, ammonium sulfate, ammonium acetate, and ammonium phosphate, other nitrogen-containing compounds, and peptone, meat extract, yeast extract, corn steep liquor, Casein hydrolyzate, soybean meal and soybean meal hydrolyzate, various fermented cells and digested products thereof can be used.
- inorganic salts for example, monopotassium phosphate, dipotassium phosphate, magnesium phosphate, magnesium sulfate, sodium chloride, ferrous sulfate, manganese sulfate, copper sulfate and calcium carbonate can be used.
- Cultivation of prokaryotes such as E. coli or eukaryotes such as yeast can be performed under aerobic conditions such as shaking culture or deep aeration and agitation culture.
- the culture temperature is, for example, 15 to 40 ° C.
- the culture time is usually 16 hours to 7 days.
- the pH of the culture medium during the culture is preferably maintained at 3.0 to 9.0.
- the pH of the culture medium can be adjusted using an inorganic acid, an organic acid, an alkaline solution, urea, calcium carbonate, ammonia, or the like.
- antibiotics such as ampicillin and tetracycline may be added to the culture medium as necessary.
- an inducer may be added to the medium as necessary.
- isopropyl- ⁇ -D-thiogalactopyranoside is used when cultivating a microorganism transformed with an expression vector using the lac promoter
- indole acrylic is used when culturing a microorganism transformed with an expression vector using the trp promoter.
- An acid or the like may be added to the medium.
- Isolation and purification of the expressed modified fibroin can be performed by a commonly used method.
- the host cell is recovered by centrifugation after culturing, suspended in an aqueous buffer, and then subjected to an ultrasonic crusher, a French press, a Manton Gaurin.
- the host cells are disrupted with a homogenizer, dynomill, or the like to obtain a cell-free extract.
- a method usually used for protein isolation and purification that is, a solvent extraction method, a salting-out method using ammonium sulfate, a desalting method, an organic solvent, etc.
- Precipitation method anion exchange chromatography method using resin such as diethylaminoethyl (DEAE) -Sepharose, DIAION HPA-75 (manufactured by Mitsubishi Kasei), positive using resin such as S-Sepharose FF (manufactured by Pharmacia)
- Electrophoresis methods such as ion exchange chromatography, hydrophobic chromatography using resins such as butyl sepharose and phenyl sepharose, gel filtration using molecular sieve, affinity chromatography, chromatofocusing, isoelectric focusing Using methods such as these alone or in combination, purification It is possible to obtain the goods.
- the modified fibroin when expressed by forming an insoluble substance in the cell, the host cell is similarly collected, crushed, and centrifuged to collect the modified fibroin insoluble substance as a precipitate fraction.
- the recovered insoluble form of modified fibroin can be solubilized with a protein denaturant.
- a purified preparation of modified fibroin can be obtained by the same isolation and purification method as described above.
- the protein when secreted extracellularly, the protein can be recovered from the culture supernatant. That is, a culture supernatant is obtained by treating the culture with a technique such as centrifugation, and a purified preparation can be obtained from the culture supernatant by using the same isolation and purification method as described above.
- a plasmid expression strain of modified silk fibroin fiber was prepared as follows. Based on the base sequence and amino acid sequence of fibroin derived from Nephila clavipes (GenBank accession numbers: P46804.1, GI: 1174415), a modified silk fibroin having the amino acid sequence represented by SEQ ID NO: 36 (hereinafter referred to as Also called “PRT918”.
- the amino acid sequence represented by SEQ ID NO: 36 is The amino acid sequence of fibroin derived from Nephila clavipes has an amino acid sequence in which substitution, insertion and deletion of amino acid residues are performed for the purpose of improving productivity, -The amino acid sequence shown in SEQ ID NO: 5 (tag sequence and hinge sequence) is added to the end, -Furthermore, QQ in the amino acid sequence is all substituted with VF, and the remaining Q is substituted with I.
- nucleic acid encoding PRT918 was synthesized.
- the nucleic acid was added with an NdeI site at the 5 ′ end and an EcoRI site downstream of the stop codon.
- the nucleic acid was cloned into a cloning vector (pUC118; see JP2002-238569). Thereafter, the nucleic acid was digested with NdeI and EcoRI and cut out, and then recombined into a protein expression vector pET-22b (+) (see JP2002-238569) to obtain an expression vector.
- Escherichia coli BLR (DE3) was transformed with a pET22b (+) expression vector containing a nucleic acid encoding a protein having the amino acid sequence represented by SEQ ID NO: 36.
- the transformed Escherichia coli was cultured in 2 mL of LB medium containing ampicillin for 15 hours.
- the culture solution was added to 100 mL of a seed culture medium (Table 4) containing ampicillin so that the OD 600 (optical density at 600 nm) was 0.005.
- the culture temperature was maintained at 30 ° C., and flask culture was performed until the OD 600 reached 5 (about 15 hours) to obtain a seed culture solution.
- the seed culture was added to a jar fermenter to which 500 mL of production medium (Table 5) was added so that the OD 600 was 0.05.
- the culture solution temperature was kept at 37 ° C., and the culture was controlled at a constant pH of 6.9.
- the dissolved oxygen concentration in the culture solution was maintained at 20% of the dissolved oxygen saturation concentration.
- a feed solution (glucose 455 g / L, Yeast Extract 120 g / L) was added at a rate of 1 mL / min.
- the culture solution temperature was maintained at 37 ° C., and the culture was controlled at a constant pH of 6.9. Further, the dissolved oxygen concentration in the culture solution was maintained at 20% of the dissolved oxygen saturation concentration, and cultured for 20 hours. Thereafter, 1M isopropyl- ⁇ -thiogalactopyranoside (IPTG) was added to the culture solution to a final concentration of 1 mM to induce expression of the modified fibroin.
- IPTG isopropyl- ⁇ -thiogalactopyranoside
- the cells recovered 2 hours after the addition of IPTG were washed with 20 mM Tris-HCl buffer (pH 7.4).
- the washed cells were suspended in 20 mM Tris-HCl buffer (pH 7.4) containing about 1 mM PMSF (phenylmethylsulfonyl fluoride), and the cells were disrupted with a high-pressure homogenizer (GEA Niro Soavi).
- the disrupted cells were centrifuged to obtain a precipitate.
- the resulting precipitate was washed with 20 mM Tris-HCl buffer (pH 7.4) until high purity.
- the washed precipitate is suspended in 8M guanidine buffer (8M guanidine hydrochloride, 10 mM sodium dihydrogen phosphate, 20 mM NaCl, 1 mM Tris-HCl, pH 7.0) to a concentration of 100 mg / mL, and 30 ° C. at 30 ° C. Stir with a stirrer for minutes to dissolve.
- dialysis was performed with water using a dialysis tube (cellulose tube 36/32 manufactured by Sanko Junyaku Co., Ltd.).
- the white aggregated protein obtained after dialysis was recovered by centrifugation, the water was removed by a freeze dryer, and the freeze-dried powder was recovered to obtain an artificial silk fibroin “PRT918”.
- modified silk protein fiber After adding the above-mentioned modified fibroin (PRT918) to DMSO so that it might become a 24 mass% density
- DMSO dimethyl sulfoxide
- a plurality of artificial silk filaments made of artificial silk protein and wound on a bobbin were bundled and cut into an average length of 40 mm with a desktop fiber cutter to form a staple bundle.
- the staple was immersed in water at 40 ° C. for 1 minute, crimped, and then dried at 40 ° C. for 18 hours to obtain a crimped staple.
- the obtained staple was spun by a known spinning device (four-spindle card spinning machine and mule spinning machine) to obtain a spun yarn made of artificial silk protein fiber.
- the yarn count of spun yarn was 30 Nm, and the number of twists was Z340.
- the contact condition with water is arbitrary, and it may be immersed in an aqueous solvent such as water-methanol or water-ethanol, or may be stored in a high humidity atmosphere to absorb water.
- the crimpability of the artificial protein fiber is not always sufficient, and the staple may be stretched by spinning and the crimp may not be noticeable.
- textile products using such spun yarn have not been sufficiently textured such as swelling. Furthermore, the above textile products are difficult to shrink.
- Protein permeation may be applied to protein fiber filaments or staples or spun yarns or to textile products.
- the knitted fabric was knitted by a 14 gauge circular knitting machine using a spun yarn obtained by twisting a plurality of staples of the artificial silk protein fiber.
- Example 1-6 The knitted fabric was dipped in the above hydrolyzed keratin aqueous solution to crimp the staples and shrink the textile product.
- Example 1-6 it was immersed in an aqueous solution (pH about 7) of feather-derived hydrolyzed keratin (number average molecular weight 1500), and the bath ratio (mass ratio of knitted fabric and hydrolyzed keratin aqueous solution) was 1:20.
- the hydrolyzed keratin aqueous solution and the knitted fabric were stirred in a paddle dyeing machine. At this time, the knitted fabric moved gently in the aqueous solution, and there was no violent collision between the knitted fabric and the container wall.
- the purpose of stirring is that the knitted fabric comes into uniform contact with the aqueous solution of hydrolyzed keratin, and the aqueous solution of hydrolyzed keratin penetrates to the inside of the spun yarn constituting the knitted fabric, and does not apply an impact to the knitted fabric. .
- the concentration of the aqueous solution of hydrolyzed keratin was varied in the range of 0.01 mass% to 0.5 mass%, centering on 0.5 mass% to 0.1 mass%.
- the immersion time was varied from 10 minutes to 480 minutes, centering on 60 minutes.
- the temperature of the aqueous solution of hydrolyzed keratin was changed in the range of 10 ° C to 95 ° C, centering on 40 ° C.
- Example 7 A 0.2 mass% aqueous solution of commercially available hydrolyzed silk (number average molecular weight 1000) obtained by hydrolyzing silk-derived fibroin was prepared. Using a paddle dyeing machine, the knitted fabric was immersed in a bath ratio of 1:20, a liquid temperature of 40 ° C., and an immersion time of 60 minutes, and treated in the same manner as in Examples 1 to 6. This is Example 7.
- Comparative Example 1 the same treatment as that of normal crimping performed on wool knitted fabric was performed. That is, instead of using an aqueous solution of hydrolyzed keratin, simple water was used, the paddle dyeing machine was changed to a washer dyeing machine, and the knitted fabric collided with the wall of the dyeing machine. The bath ratio was 1:20, the treatment temperature was 40 ° C., and the treatment time was 20 minutes.
- a paddle dyeing machine was used in the same manner as in the example, but the effect of agitation itself by the paddle dyeing machine was examined using simple water instead of an aqueous solution of hydrolyzed keratin. In addition to this, untreated knitted fabrics were evaluated while being knitted.
- Example 1 staples were strongly crimped, spun yarns were swollen, and the texture of the knitted fabric was improved. In addition, the stitches are clogged in the course direction (lateral direction in each figure) and in the wale direction (vertical direction in each figure), and the gap between the stitches becomes small, and the knitted fabric has been successfully contracted. .
- Comparative Example 2 a paddle dyeing machine was used in the same manner as in the example, and the keratin concentration was set to 0, and ligature was attempted. The crimp was slightly revived and the number of eyes decreased slightly along the wale direction, but it did not shrink.
- crimping may be performed by dipping in an aqueous solution of hydrolyzed keratin at the stage of spinning yarn.
- the concentration of the aqueous solution of hydrolyzed keratin was changed in the range from 0.01 mass% to 0.5 mass%, but in all cases, the crimp was restored and the contraction was successful. However, if it is less than 0.1 mass%, a long treatment time is required, so the keratin concentration is preferably 0.1 mass% or more. Moreover, in order to set it as a mild process, 2 mass% or less is preferable.
- the immersion time was 10 minutes to 480 minutes, but the treatment time was too long at 480 minutes. Further, when the keratin concentration is further increased from Example 2 (keratin concentration 0.5 mass%), a shorter time may be used. For these reasons, the immersion time is preferably from 5 minutes to 120 minutes.
- the temperature of the aqueous solution of hydrolyzed keratin was 95 ° C. (Example 6), the knitted fabric after the treatment became hard and the texture decreased. Further, at 10 ° C., the processing time was 4 times longer than at 40 ° C. For these reasons, the temperature of the aqueous solution is preferably 30 ° C. or higher and 60 ° C. or lower. In the example, the treatment was possible with a small bath ratio of 1:20. Therefore, there is little waste water and the environmental load is small.
- the aqueous solution of keratin may contain other components such as a chelating agent, metal salt, ceramide, lipid, citric acid, surfactant, pH adjusting agent, preservative, ethanol, and methanol in addition to water and keratin.
- a washer dyeing machine or the like may be used instead of the paddle dyeing machine, and the type of the immersion device is arbitrary. However, it is preferable to immerse the spun yarn or the textile product with gentle agitation because crimps can be generated without colliding with the wall of the vessel.
- Example 7 by using hydrolyzed silk (number average molecular weight 1000), the crimp was restored and contraction was successful. From this, it is understood that not only hydrolyzed keratin but also an aqueous solution of collagen, artificial protein or the like may be used. In Example 7, crimping of the staples after the treatment was insufficient, and compared to Example 1, the knitted fabric after crimping was insufficient in the elasticity (feeling of swelling) and the waist (the tendency to maintain the form). It was.
- Keratin includes low molecular weight hydrolyzed keratin (number average molecular weight of 500 to 5000) and high molecular weight solubilized keratin (number average molecular weight of about 10,000, for example). It has been found that an aqueous solution of hydrolyzed keratin can crimp the staple and crimp the knitted fabric, and the number average molecular weight is particularly preferably 500 or more and 3000 or less. However, these effects were insufficient with solubilized keratin. Thus, we examined how keratin acts on artificial silk protein staples when immersed in an aqueous solution of hydrolyzed keratin.
- the protein fiber is not limited to an artificial silk protein fiber, but may be an artificial silk in which amino acid residues are similarly introduced.
- semi-synthetic protein fibers such as promix and sinon, or regenerated protein fibers such as casein protein fiber, peanut protein fiber, corn protein fiber, and soy protein fiber may be used.
- the dyed one was used as an example relating to dyeing and crimping, and the dyed product without treatment with hydrolyzed keratin was used as a comparative example.
- an aqueous solution of hydrolyzed keratin (number average molecular weight 1500) (concentration 0.1 mass%, pH about 7, liquid temperature 40 ° C., 20 L of keratin aqueous solution per 1 kg of knitted fabric) in a paddle dyeing machine for 60 minutes, A knitted fabric made of artificial protein fibers was immersed.
- a preferred range of pH is 6 to 8, particularly 6.5 to 7.5, and a preferred temperature range is 30 ° C.
- the concentration is preferably 0.01 mass% or more and 0.5 mass% or less, and particularly preferably 0.02 mass% or more and 0.5 mass% or less.
- the immersion time is preferably 40 minutes or more and 80 minutes or less, and the keratin absorption amount of the fiber becomes the maximum after the immersion time of about 60 minutes.
- the paddle dyeing machine circulates the water stream of the keratin aqueous solution while contacting the knitted fabric, and the contact method between the keratin aqueous solution and the knitted fabric is arbitrary.
- the knitted fabric was treated with the keratin aqueous solution, but the form of the artificial protein fiber when treated with the keratin aqueous solution, such as the fiber itself, spun yarn, woven fabric, non-woven fabric, and textile product, is arbitrary.
- a column for liquid chromatography (Econopack column manufactured by BIO-RAD) was packed with 1 g of artificial protein fiber.
- a keratin aqueous solution (40 ° C, 0.1 mass%) with a number average molecular weight of 1500 is circulated through the column for 120 minutes, the keratin concentration is measured by gel filtration chromatography before and after passing through the fiber, and the total amount absorbed into the fiber is measured. did.
- the fiber was exchanged and measured three times.
- the average value of the total absorption amount is shown in Table 7 as a relative value with the absorption amount at 60 minutes being 1. In all three cases, there was a peak of absorption at an immersion time of 60 minutes.
- the knitted fabric After immersing in keratin aqueous solution, the knitted fabric was dehydrated and naturally dried. As in the case of the fiber made of artificial silk protein, the knitted fabric contracted and the fiber crimped by hydrolyzed keratin treatment.
- the examples related to staining and crimping are the same as the examples related to crimping except for the points specifically pointed out, and the description of the examples related to crimping is also applied to the examples related to dyeing and crimping as it is except for the points specifically pointed out.
- a weakly acidic aqueous solution for example, acetic acid aqueous solution
- a pH of 5.5 preferably a pH of 5 or more and 6 or less
- the keratin binds stably to the knitted fabric and improves durability to washing Confirmed to do.
- the inventor presumed that this phenomenon was caused by the formation of a kind of polymerization or association by combining several keratins penetrating the fibers into each other. Direct dyes and wool reactive dyes used for dyeing are weakly acidic, and keratin is more firmly fixed to the fiber by dyeing.
- the knitted fabric was dyed with four kinds of wool reactive dyes.
- the yellow dye is LANAZOL Yellow 4G, (LANAZOL is a registered trademark of Huntsman) 3% (owf) anhydrous sodium sulfate (Na 2 SO 4 ) 10% (owf) acetic acid 1% (owf)
- red dye is LANAZOL Red 6G, 3% (owf) anhydrous sodium sulfate 10% (owf) acetic acid 1% (owf)
- black dye is LANAZOLDeep Black CE-R, 7% (owf) anhydrous sodium sulfate 5% (owf) acetic acid 4% (owf)
- blue dye is LANAZOL Blue 3G, 3% (owf) anhydrous sodium sulfate 10% (owf) acetic acid 1% (owf).
- Light fastness indicates fastness to light
- wash fastness indicates fastness to washing.
- Washing fastness contamination represents the degree of color transfer to the surrounding white fabric by washing.
- Sweat contamination (acid) represents the degree of color transfer due to acidic simulated sweat to the surrounding white fabric
- sweat contamination (alkaline acid) represents the degree of color transfer due to alkaline simulated sweat.
- the fastness to friction represents the degree of color transfer when the dyed knitted fabric is rubbed with a white cloth during drying.
- Dry cleaning contamination represents the extent of dye elution into a perfluoroethylene solvent for dry cleaning. The higher the dyeing fastness, the better, and practically it should be at least 2.5 or higher.
- the hydrolyzed keratin treatment improved the test items with insufficient fastness, and the yellow and red color fastness was less than grade 3.
- sweat contamination to acids and alkalis with a fastness of 1.5 is improved to 2.5.
- the increase in dyeing fastness means that the binding strength between the dye and the fiber is improved by the feather hydrolyzed keratin derived from waterfowl absorbed into the artificial protein fiber.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Textile Engineering (AREA)
- Insects & Arthropods (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mechanical Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
Abstract
Description
・ タンパク質繊維あるいはその紡績糸をクリンプさせる新規な方法、及びクリンプしたタンパク質繊維の製造方法を提供すること、
・ 前記のタンパク質繊維あるいは紡績糸から成るテキスタイル製品を縮絨する方法を提供すること、及び
・ クリンプしたタンパク質繊維とクリンプした紡績糸、及び前記のタンパク質繊維あるいは紡績糸を用い縮絨されたテキスタイル製品を提供することを、課題とする。
タンパク質繊維を構成するタンパク質は構造タンパク質であってもよく、構造タンパク質はフィブロインであってもよい。フィブロインは天然フィブロインであってもよく、改変フィブロイン(人工フィブロイン)あってもよい。また、改変フィブロインは蜘蛛糸フィブロインであってもよく、この改変蜘蛛糸フィブロインは、疎水性アミノ酸残基が人工的に導入されているものであってもよく、若しくは親水性アミノ酸残基が人工的に導入されているものであってもよい。
改変フィブロインは、式1:[(A)nモチーフ-REP]m、又は式2:[(A)nモチーフ-REP]m-(A)nモチーフで表されるドメイン配列を含むタンパク質である。改変フィブロインは、ドメイン配列のN末端側及びC末端側のいずれか一方又は両方に更にアミノ酸配列(N末端配列及びC末端配列)が付加されていてもよい。N末端配列及びC末端配列は、これに限定されるものではないが、典型的には、フィブロインに特徴的なアミノ酸モチーフの反復を有さない領域であり、100残基程度のアミノ酸からなる。
式1:[(A)nモチーフ-REP]m、又は式2:[(A)nモチーフ-REP]m-(A)nモチーフで表されるドメイン配列を含むフィブロイン(改変フィブロイン又は天然由来のフィブロイン)において、最もC末端側に位置する(A)nモチーフからドメイン配列のC末端までの配列をドメイン配列から除いた配列に含まれる全てのREPにおいて、その領域に含まれるGPGXXモチーフの個数の総数を3倍した数(即ち、GPGXXモチーフ中のG及びPの総数に相当)をsとし、最もC末端側に位置する(A)nモチーフからドメイン配列のC末端までの配列をドメイン配列から除き、更に(A)nモチーフを除いた全REPのアミノ酸残基の総数をtとしたときに、GPGXXモチーフ含有率はs/tとして算出される。
式1:[(A)nモチーフ-REP]m、又は式2:[(A)nモチーフ-REP]m-(A)nモチーフで表されるドメイン配列を含むフィブロイン(改変フィブロイン又は天然由来のフィブロイン)において、最もC末端側に位置する(A)nモチーフからドメイン配列のC末端までの配列をドメイン配列から除いた配列(図3の「領域A」に相当する配列。)に含まれる全てのREPにおいて、その領域に含まれるグルタミン残基の総数をuとし、最もC末端側に位置する(A)nモチーフからドメイン配列のC末端までの配列をドメイン配列から除き、更に(A)nモチーフを除いた全REPのアミノ酸残基の総数をtとしたときに、グルタミン残基含有率はu/tとして算出される。グルタミン残基含有率の算出において、「最もC末端側に位置する(A)nモチーフからドメイン配列のC末端までの配列をドメイン配列から除いた配列」を対象としている理由は、上述した理由と同様である。
式1:[(A)nモチーフ-REP]m、又は式2:[(A)nモチーフ-REP]m-(A)nモチーフで表されるドメイン配列を含むフィブロイン(改変フィブロイン又は天然由来のフィブロイン)において、最もC末端側に位置する(A)nモチーフからドメイン配列のC末端までの配列をドメイン配列から除いた配列(図1の「領域A」に相当する配列。)に含まれる全てのREPにおいて、その領域の各アミノ酸残基の疎水性指標の総和をvとし、最もC末端側に位置する(A)nモチーフからドメイン配列のC末端までの配列をドメイン配列から除き、更に(A)nモチーフを除いた全REPのアミノ酸残基の総数をtとしたときに、REPの疎水性度はv/tとして算出される。REPの疎水性度の算出において、「最もC末端側に位置する(A)nモチーフからドメイン配列のC末端までの配列をドメイン配列から除いた配列」を対象としている理由は、上述した理由と同様である。
上記いずれの実施形態に係る改変フィブロイン(タンパク質)も、例えば、当該タンパク質をコードする核酸配列と、当該核酸配列に作動可能に連結された1又は複数の調節配列とを有する発現ベクターで形質転換された宿主により、当該核酸を発現させることにより生産することができる。
以下のようにして、プラスミド発現株を作製した。ネフィラ・クラビペス(Nephila clavipes)由来のフィブロイン(GenBankアクセッション番号:P46804.1、GI:1174415)の塩基配列及びアミノ酸配列に基づき、配列番号36で示されるアミノ酸配列を有する改変蜘蛛糸フィブロイン(以下、「PRT918」ともいう。)を設計した。なお、配列番号36で示されるアミノ酸配列は、
・ ネフィラ・クラビペス由来のフィブロインのアミノ酸配列に対して、生産性の向上を目的としてアミノ酸残基の置換、挿入及び欠失を施したアミノ酸配列を有すると共に、
・ 末端に、配列番号5で示されるアミノ酸配列(タグ配列及びヒンジ配列)が付加され、
・ さらにアミノ酸配列中のQQを全てVFに置換し、かつ残りのQをIに置換したものである。
次に、PRT918をコードする核酸を合成した。当該核酸には、5'末端にNdeIサイト及び終止コドン下流にEcoRIサイトを付加した。当該核酸をクローニングベクター(pUC118;JP2002-238569参照)にクローニングした。その後、同核酸をNdeI及びEcoRIで制限酵素処理して切り出した後、タンパク質発現ベクターpET-22b(+)(JP2002-238569参照)に組換えて発現ベクターを得た。
配列番号36で示されるアミノ酸配列を有するタンパク質をコードする核酸を含むpET22b(+)発現ベクターにより、大腸菌BLR(DE3)を形質転換した。当該形質転換大腸菌を、アンピシリンを含む2mLのLB培地で15時間培養した。当該培養液を、アンピシリンを含む100mLのシード培養用培地(表4)にOD600(600nmでの光学濃度)が0.005となるように添加した。培養液温度を30℃に保ち、OD600が5になるまでフラスコ培養を行い(約15時間)、シード培養液を得た。
IPTGを添加してから2時間後に回収した菌体を20mM Tris-HCl buffer(pH7.4)で洗浄した。洗浄後の菌体を約1mMのPMSF(フッ化フェニルメチルスルホニル)を含む20mM Tris-HCl緩衝液(pH7.4)に懸濁させ、高圧ホモジナイザー(GEA Niro Soavi社製)で細胞を破砕した。破砕した細胞を遠心分離し、沈殿物を得た。得られた沈殿物を、高純度になるまで20mMTris-HCl緩衝液(pH7.4)で洗浄した。洗浄後の沈殿物を100mg/mLの濃度になるように8M グアニジン緩衝液(8Mグアニジン塩酸塩、10mMリン酸二水素ナトリウム、20mMNaCl、1mMTris-HCl、pH7.0)で懸濁し、60℃で30分間、スターラーで撹拌し、溶解させた。溶解後、透析チューブ(三光純薬株式会社製のセルロースチューブ36/32)を用いて水で透析を行った。透析後に得られた白色の凝集タンパク質を遠心分離により回収し、凍結乾燥機で水分を除き、凍結乾燥粉末を回収することにより、人工蜘蛛糸フィブロイン「PRT918」を得た。
DMSOに、上述の改変フィブロイン(PRT918)を24mass%濃度となるよう添加した後、溶解促進剤としてLiClを4.0mass%となるように添加した。その後、シェーカーを使用して、改変フィブロインを3時間かけて溶解させ、DMSO(ジメチルスルホキシド)溶液を得た。得られたDMSO溶液中のゴミと泡を取り除き、ドープ液とした。ドープ液の溶液粘度は90℃において5000cP(センチポアズ)であった。
凝固液(メタノール)の温度:5~10℃
延伸倍率: 4.52倍
乾燥温度: 80℃
人工蜘蛛糸タンパク質から成り、ボビンに巻きとられた人工蜘蛛糸フィラメントを複数本束ね、卓上型繊維裁断機で平均40mm長に裁断し、ステープルの束とした。ステープルを40℃の水に1分浸漬し、クリンプさせた後、40℃で18時間乾燥させて、クリンプしたステープルを得た。得られたステープルを公知の紡績装置(4山カード紡績機とミュール精紡機)により紡績し、人工蜘蛛糸タンパク質繊維からなる紡績糸を得た。なお紡績糸の番手は30Nm、撚り数はZ340であった。水との接触条件は任意で、水-メタノール、水-エタノール等の水性溶媒に浸漬してもよく、あるいは高湿雰囲気に保管して水を吸収させても良い。
前記の改変フィブロイン(PRT918)を用い、既に説明した実施例に従って人工タンパク質繊維と紡績糸を製造した。この紡績糸を用い、14ゲージの編機により編地を編成した。この編地を加水分解ケラチン水溶液に浸漬し、クリンプ性の向上と、染色堅牢度の向上について試験した。
Claims (31)
- 刺激に応答してクリンプするクリンプ性を有するタンパク質繊維を、前記タンパク質繊維とは組成が異なるタンパク質の溶液に浸漬し、前記タンパク質繊維の内部に前記組成が異なるタンパク質を浸透させることにより、前記タンパク質繊維をクリンプさせる、クリンプ方法。
- 前記タンパク質繊維が人工タンパク質から成ることを特徴とする、請求項1に記載のクリンプ方法。
- 前記人工タンパク質が人工蜘蛛糸タンパク質から成ることを特徴とする、請求項2に記載のクリンプ方法。
- 前記タンパク質繊維のフィラメントをカットしたステープルを、前記タンパク質溶液に浸漬することを特徴とする、請求項1~3のいずれかに記載のクリンプ方法。
- 前記ステープルを複数本撚り合わせた紡績糸を、前記タンパク質の溶液に浸漬することを特徴とする、請求項4に記載のクリンプ方法。
- 前記紡績糸から成るテキスタイル製品を、前記タンパク質の溶液に浸漬することにより、テキスタイル製品を縮絨することを特徴とする、請求項5に記載のクリンプ方法。
- 前記テキスタイル製品に衝撃が加わらない条件で、前記テキスタイル製品を前記タンパク質の溶液に浸漬することを特徴とする、請求項6に記載のクリンプ方法。
- 前記タンパク質の溶液が加水分解ケラチンの水溶液であることを特徴とする、請求項1~7のいずれかに記載のクリンプ方法。
- 前記加水分解ケラチンの数平均分子量が500以上5000以下あることを特徴とする、請求項8に記載のクリンプ方法。
- 前記加水分解ケラチンの水溶液の、前記テキスタイル製品の浸漬前での、ケラチン濃度が0.1mass%以上2mass%以下、浸漬時間が5分以上120分以下であることを特徴とする、請求項8または9に記載のクリンプ方法。
- 前記加水分解ケラチンの水溶液の温度が30℃以上60℃以下であることを特徴とする、請求項8~10いずれかに記載のクリンプ方法。
- 前記組成が異なるタンパク質により前記タンパク質繊維の染色性を改善することを特徴とする、請求項2に記載のクリンプ方法。
- 前記組成が異なるタンパク質が加水分解ケラチンであることを特徴とする、請求項12に記載のクリンプ方法。
- 加水分解ケラチンの水溶液へ前記タンパク質繊維を40分以上80分以下浸漬することを特徴とする、請求項13に記載のクリンプ方法。
- 刺激に応答してクリンプするクリンプ性を有するタンパク質繊維を、前記タンパク質繊維とは組成が異なるタンパク質の溶液に浸漬し、前記タンパク質繊維の内部に前記組成が異なるタンパク質を浸透させることによりクリンプさせる工程を含む、タンパク質繊維の製造方法。
- 前記タンパク質繊維が人工タンパク質から成ることを特徴とする、請求項15に記のタンパク質繊維の製造方法。
- 前記人工タンパク質が人工蜘蛛糸タンパク質から成ることを特徴とする、請求項16に記載のタンパク質繊維の製造方法。
- 前記タンパク質の溶液が加水分解ケラチンの水溶液であることを特徴とする、請求項15~17のいずれかに記載のタンパク質繊維の製造方法。
- 前記組成が異なるタンパク質により前記タンパク質繊維の染色性を改善することを特徴とする、請求項16に記載のタンパク質繊維の製造方法。
- 前記組成が異なるタンパク質が加水分解ケラチンであることを特徴とする、請求項19に記載のタンパク質繊維の製造方法。
- 前記組成が異なるタンパク質が加水分解ケラチンであり、加水分解ケラチンの水溶液へ前記タンパク質繊維を40分以上80分以下浸漬することを特徴とする、請求項20に記載のタンパク質繊維の製造方法。
- 刺激に応答してクリンプするクリンプ性を有するタンパク質母体繊維の内部に、前記タンパク質母体繊維とは組成が異なるタンパク質が浸透しかつクリンプしている、タンパク質繊維。
- 前記タンパク質繊維がフィラメント又はフィラメントをカットしたステープルであることを特徴とする、請求項22に記載のタンパク質繊維。
- 前記タンパク質母体繊維が人工タンパク質から成ることを特徴とする、請求項22または23に記載のタンパク質繊維。
- 前記人工タンパク質が、人工蜘蛛糸タンパク質から成ることを特徴とする、請求項22~24のいずれかに記載のタンパク質繊維。
- 前記タンパク質が加水分解ケラチンであることを特徴とする、請求項22~25のいずれかに記載のタンパク質繊維。
- 前記組成が異なるタンパク質により前記タンパク質繊維の染色性が改善されていることを特徴とする、請求項24に記載のタンパク質繊維。
- 前記組成が異なるタンパク質が加水分解ケラチンであることを特徴とする、請求項27に記載のタンパク質繊維。
- 請求項22~28の何れかに記載のタンパク質繊維のステープルが複数本撚り合わされている、紡績糸。
- 請求項22~28のいずれかに記載のタンパク質繊維を用いて成るテキスタイル製品。
- 請求項29の紡績糸から成るテキスタイル製品。
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/982,612 US20210017672A1 (en) | 2018-03-22 | 2019-03-20 | Protein fiber crimping method, protein fiber production method, protein fibers, spun yarn, and textile product |
EP19770452.1A EP3770317A4 (en) | 2018-03-22 | 2019-03-20 | PROTEIN FIBER CREPING METHOD, PROTEIN FIBER PRODUCTION METHOD, PROTEIN FIBERS, SPUN YARN AND TEXTILE PRODUCT |
CN201980021072.5A CN112292487A (zh) | 2018-03-22 | 2019-03-20 | 蛋白纤维的卷曲方法、蛋白纤维的制造方法、蛋白纤维、细纱、及纺织品 |
JP2020507887A JP7453138B2 (ja) | 2018-03-22 | 2019-03-20 | タンパク質繊維のクリンプ方法、タンパク質繊維の製造方法、タンパク質繊維、紡績糸、及びテキスタイル製品 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018053915 | 2018-03-22 | ||
JP2018-053915 | 2018-03-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2019182040A1 true WO2019182040A1 (ja) | 2019-09-26 |
Family
ID=67986195
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2019/011807 WO2019182040A1 (ja) | 2018-03-22 | 2019-03-20 | タンパク質繊維のクリンプ方法、タンパク質繊維の製造方法、タンパク質繊維、紡績糸、及びテキスタイル製品 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20210017672A1 (ja) |
EP (1) | EP3770317A4 (ja) |
JP (1) | JP7453138B2 (ja) |
CN (1) | CN112292487A (ja) |
WO (1) | WO2019182040A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020067553A1 (ja) * | 2018-09-28 | 2020-04-02 | 株式会社島精機製作所 | タンパク質紡績糸の製造方法 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019194245A1 (ja) * | 2018-04-03 | 2019-10-10 | Spiber株式会社 | 高収縮人造フィブロイン紡績糸及びその製造方法、並びに人造フィブロイン紡績糸及びその収縮方法 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5430955A (en) * | 1977-08-12 | 1979-03-07 | Shigesaburou Mizushima | Crimped silk yarn and production thereof |
JPS6262990A (ja) * | 1985-09-11 | 1987-03-19 | 大東紡織株式会社 | 形状記憶毛糸の製造方法 |
JPS63249780A (ja) * | 1987-04-03 | 1988-10-17 | 水島 繁三郎 | 形状記憶アクリル・蛋白共重合繊維の製造方法 |
JP2002238569A (ja) | 2001-02-14 | 2002-08-27 | Higeta Shoyu Co Ltd | 大腸菌とブレビバチルス属細菌間のプラスミドシャトルベクター |
JP2014129639A (ja) | 2011-06-01 | 2014-07-10 | Spiber Inc | 人造ポリペプチド繊維の製造方法 |
WO2017038814A1 (ja) | 2015-08-31 | 2017-03-09 | 株式会社島精機製作所 | 加工繊維の製造方法及び当該加工繊維、動物繊維の損傷抑制方法、並びに動物繊維の加工方法 |
WO2017188430A1 (ja) * | 2016-04-28 | 2017-11-02 | Spiber株式会社 | 改変フィブロイン |
WO2019066006A1 (ja) * | 2017-09-29 | 2019-04-04 | Spiber株式会社 | 撚糸の製造方法、仮撚り糸の製造方法、及び糸の撚り加工方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB403121A (en) * | 1931-06-12 | 1933-12-11 | Naugatuck Chem Co | Improvements in the treatment of knitted fabrics |
US3849848A (en) * | 1971-05-20 | 1974-11-26 | Iws Nominee Co Ltd | Method for the treatment of textile fibres |
JPS5839934A (ja) * | 1981-09-03 | 1983-03-08 | Matsushita Electric Works Ltd | 表面欠陥検出装置 |
JPS6170075A (ja) * | 1984-09-12 | 1986-04-10 | 水島 繁三郎 | 形状記憶生糸の製造方法 |
JPS6170074A (ja) * | 1984-09-12 | 1986-04-10 | 水島 繁三郎 | 形状記憶生糸及びその製造方法 |
JPS62170562A (ja) * | 1986-01-14 | 1987-07-27 | グンゼ株式会社 | ツ−ウエイ編地の製造法 |
JPH01246432A (ja) * | 1988-03-23 | 1989-10-02 | Shigesaburo Mizushima | 天然繊維記憶形状糸の製造法 |
JPH01280074A (ja) * | 1988-05-02 | 1989-11-10 | Daito Boshoku Kk | 布地およびこの布地の製造方法 |
FR2688135B1 (fr) * | 1992-03-09 | 1995-06-09 | Oreal | Composition cosmetique pour le maintien de la coiffure, contenant un proteine de lait et/ou un hydrolysat de proteine de lait et un hydrolysat de keratine. |
JPH083875A (ja) * | 1994-06-10 | 1996-01-09 | Kanebo Ltd | セット性に優れた繊維製品の製造方法 |
KR102279714B1 (ko) * | 2017-05-15 | 2021-07-19 | 가부시키가이샤 시마세이키 세이사쿠쇼 | 표면가공섬유, 그 제조방법, 실 및 섬유제품 |
-
2019
- 2019-03-20 EP EP19770452.1A patent/EP3770317A4/en active Pending
- 2019-03-20 WO PCT/JP2019/011807 patent/WO2019182040A1/ja active Application Filing
- 2019-03-20 US US16/982,612 patent/US20210017672A1/en active Pending
- 2019-03-20 CN CN201980021072.5A patent/CN112292487A/zh active Pending
- 2019-03-20 JP JP2020507887A patent/JP7453138B2/ja active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5430955A (en) * | 1977-08-12 | 1979-03-07 | Shigesaburou Mizushima | Crimped silk yarn and production thereof |
JPS6262990A (ja) * | 1985-09-11 | 1987-03-19 | 大東紡織株式会社 | 形状記憶毛糸の製造方法 |
JPS63249780A (ja) * | 1987-04-03 | 1988-10-17 | 水島 繁三郎 | 形状記憶アクリル・蛋白共重合繊維の製造方法 |
JP2002238569A (ja) | 2001-02-14 | 2002-08-27 | Higeta Shoyu Co Ltd | 大腸菌とブレビバチルス属細菌間のプラスミドシャトルベクター |
JP2014129639A (ja) | 2011-06-01 | 2014-07-10 | Spiber Inc | 人造ポリペプチド繊維の製造方法 |
WO2017038814A1 (ja) | 2015-08-31 | 2017-03-09 | 株式会社島精機製作所 | 加工繊維の製造方法及び当該加工繊維、動物繊維の損傷抑制方法、並びに動物繊維の加工方法 |
WO2017188430A1 (ja) * | 2016-04-28 | 2017-11-02 | Spiber株式会社 | 改変フィブロイン |
WO2019066006A1 (ja) * | 2017-09-29 | 2019-04-04 | Spiber株式会社 | 撚糸の製造方法、仮撚り糸の製造方法、及び糸の撚り加工方法 |
Non-Patent Citations (9)
Title |
---|
"G enBank", Database accession no. U37520 |
"GenBank", Database accession no. CAM432249.1 |
"Molecular Cloning" |
HATAE, SHINJI ET AL.: "Construction of Novel Protein Fiber Consisted of Repeated Motifes from Spider Dragline Silk", BIO INDUSTRY, vol. 22, no. 10, 2005, pages 48 - 53, XP009523509 * |
KYTE JDOOLITTLE R: "A simple method for displaying the hydropathic character of a protein", J. MOL. BIOL., vol. 157, 1982, pages 105 - 132, XP024014365, DOI: 10.1016/0022-2836(82)90515-0 |
METHODS IN ENZYMOLOGY, vol. 100, 1983, pages 448 |
NUCLEIC ACID RES., vol. 10, 1982, pages 6487 |
PROC. NATL. ACAD. SCI. USA, vol. 69, 1972, pages 2110 |
See also references of EP3770317A4 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020067553A1 (ja) * | 2018-09-28 | 2020-04-02 | 株式会社島精機製作所 | タンパク質紡績糸の製造方法 |
JPWO2020067553A1 (ja) * | 2018-09-28 | 2021-09-02 | 株式会社島精機製作所 | タンパク質紡績糸の製造方法 |
JP7466872B2 (ja) | 2018-09-28 | 2024-04-15 | 株式会社島精機製作所 | タンパク質紡績糸の製造方法 |
Also Published As
Publication number | Publication date |
---|---|
US20210017672A1 (en) | 2021-01-21 |
EP3770317A1 (en) | 2021-01-27 |
EP3770317A4 (en) | 2022-01-19 |
CN112292487A (zh) | 2021-01-29 |
JP7453138B2 (ja) | 2024-03-19 |
JPWO2019182040A1 (ja) | 2021-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2018164234A1 (ja) | タンパク質繊維の製造方法、及びタンパク質繊維の防縮方法 | |
WO2018164020A1 (ja) | タンパク質繊維の製造方法及び製造装置 | |
CN112469298B (zh) | 人工毛发用纤维及其制造方法、以及人工毛发 | |
WO2019182040A1 (ja) | タンパク質繊維のクリンプ方法、タンパク質繊維の製造方法、タンパク質繊維、紡績糸、及びテキスタイル製品 | |
WO2018164189A1 (ja) | タンパク質成形体及びこれを製造する方法、並びにタンパク質溶液 | |
WO2019194224A1 (ja) | 改変フィブロイン成形体の塑性変形体の寸法回復方法 | |
JP7330468B2 (ja) | 混紡糸並びにその編織体及びその編織体の製造方法 | |
WO2019194245A1 (ja) | 高収縮人造フィブロイン紡績糸及びその製造方法、並びに人造フィブロイン紡績糸及びその収縮方法 | |
JP7104960B2 (ja) | フィブロイン繊維の製造方法 | |
WO2019151437A1 (ja) | タンパク質紡績糸の製造方法 | |
JP7237314B2 (ja) | タンパク質繊維の製造方法、タンパク質繊維の製造装置、およびタンパク質繊維の加工方法 | |
TW202214922A (zh) | 人工毛髮用纖維、人工毛髮、製造人工毛髮用纖維之方法,及製造人工毛髮之方法 | |
JP7466872B2 (ja) | タンパク質紡績糸の製造方法 | |
JP7367977B2 (ja) | タンパク質捲縮ステープルの製造方法 | |
WO2019151432A1 (ja) | 油剤付着タンパク質捲縮繊維の製造方法 | |
JP2021120402A (ja) | タンパク質組成物 | |
WO2019151425A1 (ja) | 紡糸原液、フィブロイン繊維及びその製造方法 | |
JPWO2019066006A1 (ja) | 撚糸の製造方法、仮撚り糸の製造方法、及び糸の撚り加工方法 | |
WO2019194263A1 (ja) | 高収縮人造フィブロイン撚糸及びその製造方法、並びに人造フィブロイン撚糸及びその収縮方法 | |
TW202129103A (zh) | 人工毛髮用纖維及其製造方法 | |
WO2019151433A1 (ja) | タンパク質フィラメントの開繊トウ及びその製造方法 | |
WO2019151430A1 (ja) | タンパク質繊維糸及び編織体、並びに、タンパク質繊維糸の製造方法及び編織体の製造方法 | |
JP2021031811A (ja) | 染色された生地の製造方法及び生地の染色方法、並びに染色された混紡糸の製造方法及び混紡糸の染色方法 | |
JP2019183301A (ja) | 人造フィブロイン繊維の防縮方法、人造フィブロイン繊維及びその製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19770452 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2020507887 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2019770452 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2019770452 Country of ref document: EP Effective date: 20201022 |